HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 6.06 MAC1. 08APR25:16:40:1508APR25:16:40:15 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS _1257722SASDATA 6.06 08APR25:16:40:1508APR25:16:40:15 Disposition HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001400000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier  SUBJID Subject Identifier for the Study )DSSEQ Sequence Number BEST  2DSREFID Reference ID :DSSPID Sponsor-Defined Identifier >DSTERM Reported Term for the Disposition Event T' DSDECOD Standardized Disposition Term   DSCAT Category for Disposition Event 4 DSSCAT Subcategory for Disposition Event F EPOCH Epoch U DSSTDTC Start Date/Time of Disposition Event iDSSTDY Study Day of Start of Disposition Event BEST  s HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201DSmRNA-1273-P201-US201-1001US2011001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1001US2011001A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1003US2011003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1003US2011003A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1004US2011004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1004US2011004A 1925 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1004US2011004A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1004US2011004A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1004US2011004AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1005US2011005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1005US2011005A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1006US2011006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1006US2011006A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1007US2011007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1007US2011007A 1927 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1007US2011007A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1007US2011007A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1007US2011007AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1008US2011008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1008US2011008A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1009US2011009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1009US2011009A 1931 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1009US2011009A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1009US2011009A@ SUBJECT REQUESTED TO BE UNBLINDED AS SHE IS SCHEDULED TO RECEIVE EUA COVID-19 VACCINE THROUGH HER WORK. PI UNBLINDED AND SUBJECT WAS WITHDRAWN FROM STUDY. PHYSICIAN DECISION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-06BmRNA-1273-P201DSmRNA-1273-P201-US201-1011US2011011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US201-1011US2011011A 1912 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US201-1011US2011011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US201-1011US2011011A@ PT RECEIVED PFIZER COVID-19 VACCINE UNDER EUA, OUTSIDE OF STUDY. WITHDRAWN, PER SPONSOR INSTRUCTIONS. PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-04CmRNA-1273-P201DSmRNA-1273-P201-US201-1012US2011012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1012US2011012A 1926 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1012US2011012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1012US2011012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1012US2011012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1014US2011014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1014US2011014A 1922 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1014US2011014A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1014US2011014A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-22CpmRNA-1273-P201DSmRNA-1273-P201-US201-1014US2011014AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-22CpmRNA-1273-P201DSmRNA-1273-P201-US201-1015US2011015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1015US2011015A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1018US2011018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1018US2011018A 1044 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1018US2011018A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1018US2011018A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1018US2011018AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1019US2011019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US201-1019US2011019A 1097 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1019US2011019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1019US2011019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1019US2011019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1020US2011020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US201-1020US2011020A 1035 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1020US2011020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1020US2011020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1020US2011020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1021US2011021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1021US2011021A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1022US2011022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1022US2011022A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1023US2011023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1023US2011023A 1945 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1023US2011023A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1023US2011023A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US201-1023US2011023AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US201-1024US2011024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1024US2011024A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1027US2011027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1027US2011027A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1028US2011028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1028US2011028A 1917 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1028US2011028A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1028US2011028A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1028US2011028AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1029US2011029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1029US2011029A 1047 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1029US2011029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1029US2011029A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1029US2011029AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1030US2011030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1030US2011030A 1076 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1030US2011030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1030US2011030A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03C0mRNA-1273-P201DSmRNA-1273-P201-US201-1030US2011030AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03C0mRNA-1273-P201DSmRNA-1273-P201-US201-1032US2011032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1032US2011032A 1943 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1032US2011032A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1032US2011032A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1032US2011032AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1033US2011033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1033US2011033A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1034US2011034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1034US2011034A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1035US2011035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1035US2011035A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1037US2011037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1037US2011037A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1039US2011039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1039US2011039A 1039 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1039US2011039A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1039US2011039A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1039US2011039AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1040US2011040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1040US2011040A 1930 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1040US2011040A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1040US2011040A@ SUBJECT BEGAN TAKING HYDROXYCHLOROQUINE FOR COVID-19 PREVENTION. IMMUNOSUPPRESSANT DRUGS ARE EXCLUSIONARY FOR THIS STUDY. SUBJECT HAS BEEN WITHDRAWN. PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-26BmRNA-1273-P201DSmRNA-1273-P201-US201-1041US2011041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1041US2011041A 1082 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1041US2011041A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1041US2011041A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1041US2011041AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1042US2011042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US201-1042US2011042A 1251 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US201-1042US2011042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06BmRNA-1273-P201DSmRNA-1273-P201-US201-1042US2011042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1042US2011042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US201-1043US2011043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1043US2011043A 1019 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1043US2011043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1043US2011043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1043US2011043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1045US2011045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1045US2011045A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1046US2011046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1046US2011046A 1112 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1046US2011046A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1046US2011046A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1046US2011046AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1048US2011048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1048US2011048A 1024 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1048US2011048A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1048US2011048A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1048US2011048AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1049US2011049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1049US2011049A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1050US2011050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US201-1050US2011050A 1020 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US201-1050US2011050A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1050US2011050A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1050US2011050AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1051US2011051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US201-1051US2011051A 1106 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1051US2011051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US201-1051US2011051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1051US2011051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1052US2011052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1052US2011052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1053US2011053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1053US2011053A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US201-1054US2011054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1054US2011054A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1055US2011055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1055US2011055A 1109 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1055US2011055A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1055US2011055A@ SUBJECT RECEIVED COVID-19 VACCINE UNDER EUA, OUTSIDE OF THE STUDY. WITHDRAWN PER SPONSOR INSTRUCTION. PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1056US2011056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1056US2011056A 1113 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1056US2011056A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1056US2011056A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1056US2011056AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1057US2011057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1057US2011057A 1096 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1057US2011057A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1057US2011057A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-17CmRNA-1273-P201DSmRNA-1273-P201-US201-1059US2011059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1059US2011059A 1060 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1059US2011059A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1059US2011059A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1059US2011059AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1060US2011060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1060US2011060A 1087 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1060US2011060A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1060US2011060A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1060US2011060AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1061US2011061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US201-1061US2011061A 1162 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US201-1061US2011061A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1061US2011061A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1061US2011061AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1062US2011062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1062US2011062A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1063US2011063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1063US2011063A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1064US2011064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1064US2011064A 1086 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1064US2011064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1064US2011064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-17CmRNA-1273-P201DSmRNA-1273-P201-US201-1064US2011064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-17CmRNA-1273-P201DSmRNA-1273-P201-US201-1065US2011065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1065US2011065A 1090 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1065US2011065A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1065US2011065A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1065US2011065AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1066US2011066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1066US2011066A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1067US2011067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US201-1067US2011067A 1142 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US201-1067US2011067A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US201-1067US2011067A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1067US2011067AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1068US2011068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1068US2011068A 1056 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1068US2011068A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1068US2011068A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1068US2011068AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1069US2011069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US201-1069US2011069A 1062 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1069US2011069A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1069US2011069A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1069US2011069AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1070US2011070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US201-1070US2011070A 1206 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US201-1070US2011070A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US201-1070US2011070A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201DSmRNA-1273-P201-US201-1071US2011071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1071US2011071A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1072US2011072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1072US2011072A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1074US2011074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1074US2011074A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1075US2011075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1075US2011075A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1076US2011076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1076US2011076A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1077US2011077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1077US2011077A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1078US2011078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1078US2011078A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1079US2011079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1079US2011079A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1080US2011080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US201-1080US2011080A 1133 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US201-1080US2011080A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1080US2011080A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1080US2011080AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US201-1083US2011083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1083US2011083A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US201-1084US2011084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US201-1084US2011084A 1059 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1084US2011084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1084US2011084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1084US2011084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1085US2011085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US201-1085US2011085A 1153 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US201-1085US2011085A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1085US2011085A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1085US2011085AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1086US2011086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US201-1086US2011086A 1074 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1086US2011086A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1086US2011086A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1086US2011086AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1087US2011087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US201-1087US2011087A 1154 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US201-1087US2011087A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1087US2011087A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1087US2011087AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1088US2011088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US201-1088US2011088A 1168 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US201-1088US2011088A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US201-1088US2011088A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1088US2011088AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1089US2011089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01@mRNA-1273-P201DSmRNA-1273-P201-US201-1089US2011089A 1209 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US201-1089US2011089A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B$mRNA-1273-P201DSmRNA-1273-P201-US201-1089US2011089A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1089US2011089AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1090US2011090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US201-1090US2011090A 1175 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US201-1090US2011090A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1090US2011090A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1090US2011090AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US201-1091US2011091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US201-1091US2011091A 1178 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US201-1091US2011091A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1091US2011091A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CpmRNA-1273-P201DSmRNA-1273-P201-US201-1091US2011091AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CpmRNA-1273-P201DSmRNA-1273-P201-US201-1092US2011092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US201-1092US2011092A 1233 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US201-1092US2011092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US201-1092US2011092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CpmRNA-1273-P201DSmRNA-1273-P201-US201-1092US2011092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CpmRNA-1273-P201DSmRNA-1273-P201-US201-1093US2011093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US201-1093US2011093A 1247 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US201-1093US2011093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06BmRNA-1273-P201DSmRNA-1273-P201-US201-1093US2011093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-18CmRNA-1273-P201DSmRNA-1273-P201-US201-1093US2011093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-18CmRNA-1273-P201DSmRNA-1273-P201-US201-1094US2011094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1094US2011094A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US201-1095US2011095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US201-1095US2011095A 1236 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US201-1095US2011095A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US201-1095US2011095A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1095US2011095AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US201-1096US2011096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1096US2011096A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US201-1097US2011097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1097US2011097A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1098US2011098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1098US2011098A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1099US2011099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1099US2011099A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US201-1100US2011100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US201-1100US2011100A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US201-1101US2011101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US201-1101US2011101A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US201-1102US2011102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US201-1102US2011102A 1257 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US201-1102US2011102A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06BmRNA-1273-P201DSmRNA-1273-P201-US201-1102US2011102A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US201-1102US2011102AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US201-1103US2011103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US201-1103US2011103A 1271 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US201-1103US2011103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US201-1103US2011103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US201-1103US2011103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US201-1104US2011104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US201-1104US2011104A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US201-1105US2011105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US201-1105US2011105A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1106US2011106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US201-1106US2011106A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1107US2011107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US201-1107US2011107A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1108US2011108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US201-1108US2011108A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1109US2011109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US201-1109US2011109A 1995 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1109US2011109A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1109US2011109A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US201-1109US2011109AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US201-1111US2011111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US201-1111US2011111A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1112US2011112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US201-1112US2011112A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US201-1113US2011113A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US201-1113US2011113A 2135 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1113US2011113A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1113US2011113A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US201-1114US2011114A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US201-1114US2011114A 1993 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1114US2011114A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1114US2011114A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US201-1114US2011114AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US201-1115US2011115A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US201-1115US2011115A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US201-1116US2011116A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US201-1116US2011116A 2036 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-27AmRNA-1273-P201DSmRNA-1273-P201-US201-1116US2011116A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1116US2011116A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-04BmRNA-1273-P201DSmRNA-1273-P201-US201-1116US2011116AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-04BmRNA-1273-P201DSmRNA-1273-P201-US201-1117US2011117A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US201-1117US2011117A 2012 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1117US2011117A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1117US2011117A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1117US2011117AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1118US2011118A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US201-1118US2011118A 2031 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1118US2011118A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1118US2011118A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1118US2011118AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1119US2011119A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US201-1119US2011119A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US201-1120US2011120A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US201-1120US2011120A 2035 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-27AmRNA-1273-P201DSmRNA-1273-P201-US201-1120US2011120A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1120US2011120A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1120US2011120AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1121US2011121A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US201-1121US2011121A 2149 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1121US2011121A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1121US2011121A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1121US2011121AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1122US2011122A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1122US2011122A 1958 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1122US2011122A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1122US2011122A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1122US2011122AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011025A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011123A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011123A@2032 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011123AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011123A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US201-1123US2011123Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011081A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011124A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011124A@2011 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011124AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011124A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1124US2011124Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26%mRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011017A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011125A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011125A@2152 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011125AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011125A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1125US2011125Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011038A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011126A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011126A@1965 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011126AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011126A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1126US2011126Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011013A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011127A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011127A@2023 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011127AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011127A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-30C`mRNA-1273-P201DSmRNA-1273-P201-US201-1127US2011127Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-30C`mRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27"mRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011047A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011128A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011128A@2082 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011128AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011128A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1128US2011128Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011073A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011130A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011130A@2022 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011130AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011130A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US201-1130US2011130Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US201-1131US2011131A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US201-1131US2011131A 2027 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1131US2011131A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1131US2011131A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1131US2011131AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09CmRNA-1273-P201DSmRNA-1273-P201-US201-1132US2011026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1132US2011026A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US201-1132US2011132A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US201-1132US2011132A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1133US2011133A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US201-1133US2011133A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1134US2011134A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US201-1134US2011134A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1135US2011135A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US201-1135US2011135A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1136US2011136A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US201-1136US2011136A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011058A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011137A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22@mRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011137A@1961 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011137AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011137A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US201-1137US2011137Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011031A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011138A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22PmRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011138A@2034 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-27AmRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011138AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011138A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1138US2011138Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1139US2011139A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22@mRNA-1273-P201DSmRNA-1273-P201-US201-1139US2011139A 1997 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1139US2011139A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1139US2011139A@ SUBJECT MOVED OUT OF STATE. PER PI, UNABLE TO PROPERLY FOLLOW COMPLIANCE REQUIREMENTS. PHYSICIAN DECISION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201DSmRNA-1273-P201-US201-1140US2011016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1140US2011016A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US201-1140US2011140A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1140US2011140A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27!mRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011044A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011142A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22pmRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011142A@2052 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011142AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011142A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1142US2011142Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1143US2011143A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US201-1143US2011143A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1144US2011144A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US201-1144US2011144A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1145US2011145A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-230mRNA-1273-P201DSmRNA-1273-P201-US201-1145US2011145A 2009 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US201-1145US2011145A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US201-1145US2011145A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US201-1145US2011145AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US201-1146US2011082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US201-1146US2011082A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1146US2011146A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US201-1146US2011146A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US201-1147US2011147A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US201-1147US2011147A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1148US2011148A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1148US2011148A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26"mRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011010A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28 mRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011149A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25@mRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011149A@2054 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011149AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011149A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1149US2011149Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-01BmRNA-1273-P201DSmRNA-1273-P201-US201-1150US2011129A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US201-1150US2011129A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US201-1150US2011150A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1150US2011150A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1151US2011151A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1151US2011151A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1152US2011152A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25@mRNA-1273-P201DSmRNA-1273-P201-US201-1152US2011152A 2048 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US201-1152US2011152A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1152US2011152A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1152US2011152AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011141A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22pmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011141A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24PmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011153A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25@mRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011153A@2064 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011153AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011153A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1153US2011153Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1154US2011002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1154US2011002A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1154US2011154A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US201-1154US2011154A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1155US2011155A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25PmRNA-1273-P201DSmRNA-1273-P201-US201-1155US2011155A 2096 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US201-1155US2011155A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US201-1155US2011155A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1155US2011155AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1156US2011156A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25PmRNA-1273-P201DSmRNA-1273-P201-US201-1156US2011156A 2090 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US201-1156US2011156A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US201-1156US2011156A@ PT RECEIVED J & J COVID 19 VACCINE OUTSIDE OF STUDY ON 03/06/2021 PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011110A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011157A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25PmRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011157A@2101 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011157AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011157A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1157US2011157Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08BmRNA-1273-P201DSmRNA-1273-P201-US201-1158US2011036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US201-1158US2011036A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US201-1158US2011158A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US201-1158US2011158A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US201-1159US2011159A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30 mRNA-1273-P201DSmRNA-1273-P201-US201-1159US2011159A 2137 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US201-1159US2011159A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US201-1159US2011159A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10BmRNA-1273-P201DSmRNA-1273-P201-US201-1159US2011159AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10BmRNA-1273-P201DSmRNA-1273-P201-US201-1160US2011160A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US201-1160US2011160A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US201-1161US2011161A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US201-1161US2011161A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-03.mRNA-1273-P201DSmRNA-1273-P201-US201-1162US2011162A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US201-1162US2011162A 2190 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US201-1162US2011162A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US201-1162US2011162A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US201-1162US2011162AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09BmRNA-1273-P201DSmRNA-1273-P201-US202-1001US2021001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1001US2021001A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1002US2021002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1002US2021002A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1003US2021003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1003US2021003A 1911 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1003US2021003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30B!mRNA-1273-P201DSmRNA-1273-P201-US202-1003US2021003A@ SUBJECT IS UNABLE TO PARTICIPATE IN DECISION VISIT WITHDRAWAL BY SUBJECT DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-15C0mRNA-1273-P201DSmRNA-1273-P201-US202-1004US2021004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1004US2021004A 1904 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1004US2021004A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US202-1004US2021004A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US202-1004US2021004AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US202-1005US2021005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1005US2021005A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US202-1007US2021007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US202-1007US2021007A 1920 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1007US2021007A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1007US2021007A@ VACCINATION OUTSIDE OF STUDY PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US202-1007US2021007AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US202-1008US2021008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1008US2021008A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1009US2021009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1009US2021009A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US202-1011US2021011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1011US2021011A 1910 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1011US2021011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US202-1011US2021011A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US202-1011US2021011AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US202-1012US2021012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US202-1012US2021012A 1916 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1012US2021012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1012US2021012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1012US2021012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1013US2021013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1013US2021013A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1014US2021014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1014US2021014A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1015US2021015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1015US2021015A 1903 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1015US2021015A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US202-1015US2021015A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1015US2021015AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1017US2021017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1017US2021017A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1018US2021018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1018US2021018A 1906 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1018US2021018A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B.mRNA-1273-P201DSmRNA-1273-P201-US202-1018US2021018A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1018US2021018AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1019US2021019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1019US2021019A 1909 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1019US2021019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B#mRNA-1273-P201DSmRNA-1273-P201-US202-1019US2021019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1019US2021019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1020US2021020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US202-1020US2021020A 1919 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1020US2021020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US202-1020US2021020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1020US2021020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1021US2021021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US202-1021US2021021A 1905 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1021US2021021A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US202-1021US2021021A@ EUA COVID-19 VACCINE "REQUEST TO UNBLIND" PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-15BmRNA-1273-P201DSmRNA-1273-P201-US202-1022US2021022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US202-1022US2021022A 1921 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1022US2021022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B$mRNA-1273-P201DSmRNA-1273-P201-US202-1022US2021022A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1022US2021022AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1025US2021025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1025US2021025A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US202-1026US2021026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1026US2021026A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1027US2021027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1027US2021027A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1028US2021028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1028US2021028A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1030US2021030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1030US2021030A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1031US2021031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US202-1031US2021031A 1929 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1031US2021031A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1031US2021031A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1031US2021031AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1032US2021032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1032US2021032A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1033US2021033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1033US2021033A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1034US2021034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1034US2021034A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1036US2021036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1036US2021036A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1037US2021037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1037US2021037A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1038US2021038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1038US2021038A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1041US2021041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1041US2021041A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1043US2021043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US202-1043US2021043A 1928 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1043US2021043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B mRNA-1273-P201DSmRNA-1273-P201-US202-1043US2021043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1043US2021043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1045US2021045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US202-1045US2021045A 1933 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1045US2021045A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1045US2021045A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1045US2021045AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1047US2021047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US202-1047US2021047A 1932 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1047US2021047A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1047US2021047A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1047US2021047AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1048US2021048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1048US2021048A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1049US2021049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1049US2021049A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1050US2021050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1050US2021050A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1051US2021051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1051US2021051A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1052US2021052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1052US2021052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1053US2021053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1053US2021053A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1054US2021054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1054US2021054A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1055US2021055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1055US2021055A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1056US2021056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1056US2021056A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1057US2021057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1057US2021057A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1058US2021058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1058US2021058A 1205 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1058US2021058A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US202-1058US2021058A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US202-1058US2021058AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US202-1059US2021059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US202-1059US2021059A 1051 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1059US2021059A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1059US2021059A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US202-1060US2021060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1060US2021060A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1061US2021061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US202-1061US2021061A 1067 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1061US2021061A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US202-1061US2021061A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1061US2021061AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1062US2021062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1062US2021062A 1176 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US202-1062US2021062A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1062US2021062A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US202-1062US2021062AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US202-1063US2021063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1063US2021063A 1167 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US202-1063US2021063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US202-1063US2021063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-04C mRNA-1273-P201DSmRNA-1273-P201-US202-1063US2021063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-04C mRNA-1273-P201DSmRNA-1273-P201-US202-1064US2021064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1064US2021064A 1244 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1064US2021064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US202-1064US2021064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1064US2021064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1065US2021065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1065US2021065A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1066US2021066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1066US2021066A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1067US2021067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1067US2021067A 1216 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1067US2021067A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US202-1067US2021067A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1067US2021067AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1068US2021068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US202-1068US2021068A 1101 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1068US2021068A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1068US2021068A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US202-1068US2021068AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US202-1069US2021069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1069US2021069A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1071US2021071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1071US2021071A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1072US2021072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1072US2021072A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1073US2021073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US202-1073US2021073A 1080 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1073US2021073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US202-1073US2021073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1073US2021073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1074US2021074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US202-1074US2021074A 1052 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1074US2021074A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US202-1074US2021074A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US202-1074US2021074AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CmRNA-1273-P201DSmRNA-1273-P201-US202-1075US2021075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1075US2021075A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1077US2021077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1077US2021077A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1078US2021078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US202-1078US2021078A 1122 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1078US2021078A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1078US2021078A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1078US2021078AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1079US2021079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1079US2021079A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1080US2021080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1080US2021080A 1230 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1080US2021080A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US202-1080US2021080A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-04CmRNA-1273-P201DSmRNA-1273-P201-US202-1080US2021080AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-04CmRNA-1273-P201DSmRNA-1273-P201-US202-1081US2021081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1081US2021081A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1082US2021082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US202-1082US2021082A 1128 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1082US2021082A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US202-1082US2021082A@ REQUEST TO UNBLIND/ EUA COVID-19 VACCINE PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-15BmRNA-1273-P201DSmRNA-1273-P201-US202-1083US2021083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1083US2021083A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1084US2021084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1084US2021084A 1237 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1084US2021084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US202-1084US2021084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1084US2021084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1085US2021085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1085US2021085A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1086US2021086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1086US2021086A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1087US2021087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1087US2021087A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1088US2021088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1088US2021088A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1089US2021089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1089US2021089A 1269 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1089US2021089A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US202-1089US2021089A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1089US2021089AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1090US2021090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US202-1090US2021090A 1061 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1090US2021090A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US202-1090US2021090A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1090US2021090AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1091US2021091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1091US2021091A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1092US2021092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1092US2021092A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1093US2021093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US202-1093US2021093A 1119 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1093US2021093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US202-1093US2021093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1093US2021093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1094US2021094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1094US2021094A 1232 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1094US2021094A0 DS-003 #3 AE COVID DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B'mRNA-1273-P201DSmRNA-1273-P201-US202-1094US2021094A@ SUBJECT RECEIVING VACCINE OUTSIDE OF THE STUDY (EUA) PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-10CpmRNA-1273-P201DSmRNA-1273-P201-US202-1095US2021095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1095US2021095A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1096US2021096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US202-1096US2021096A 1141 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1096US2021096A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1096US2021096A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CpmRNA-1273-P201DSmRNA-1273-P201-US202-1096US2021096AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CpmRNA-1273-P201DSmRNA-1273-P201-US202-1097US2021097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1097US2021097A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1098US2021098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1098US2021098A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1099US2021099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US202-1099US2021099A 1105 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1099US2021099A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US202-1099US2021099A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US202-1099US2021099AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US202-1100US2021100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1100US2021100A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1101US2021101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1101US2021101A 1261 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1101US2021101A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US202-1101US2021101A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1101US2021101AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1102US2021102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1102US2021102A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1103US2021103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1103US2021103A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1105US2021105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1105US2021105A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1107US2021107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US202-1107US2021107A 1116 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1107US2021107A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1107US2021107A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1107US2021107AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1108US2021108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1108US2021108A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1109US2021109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1109US2021109A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1110US2021110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1110US2021110A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1111US2021111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US202-1111US2021111A 1246 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1111US2021111A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-21B,mRNA-1273-P201DSmRNA-1273-P201-US202-1111US2021111A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1111US2021111AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1112US2021112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1112US2021112A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1113US2021113A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1113US2021113A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1114US2021114A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US202-1114US2021114A 1955 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1114US2021114A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US202-1114US2021114A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1114US2021114AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1115US2021115A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US202-1115US2021115A 1973 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1115US2021115A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B$mRNA-1273-P201DSmRNA-1273-P201-US202-1115US2021115A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US202-1115US2021115AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US202-1116US2021116A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1116US2021116A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1117US2021117A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1117US2021117A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1118US2021118A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1118US2021118A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1119US2021119A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1119US2021119A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1120US2021120A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1120US2021120A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1121US2021121A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US202-1121US2021121A 1150 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US202-1121US2021121A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1121US2021121A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-19C mRNA-1273-P201DSmRNA-1273-P201-US202-1121US2021121AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-19C mRNA-1273-P201DSmRNA-1273-P201-US202-1122US2021122A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1122US2021122A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1123US2021123A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1123US2021123A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1124US2021124A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1124US2021124A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1125US2021125A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1125US2021125A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1126US2021126A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1126US2021126A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1127US2021127A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1127US2021127A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1128US2021128A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1128US2021128A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1129US2021129A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1129US2021129A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1130US2021130A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01mRNA-1273-P201DSmRNA-1273-P201-US202-1130US2021130A 1968 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1130US2021130A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US202-1130US2021130A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1130US2021130AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1131US2021131A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1131US2021131A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1132US2021132A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1132US2021132A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1133US2021133A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01mRNA-1273-P201DSmRNA-1273-P201-US202-1133US2021133A 1988 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1133US2021133A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US202-1133US2021133A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1133US2021133AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1134US2021134A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1134US2021134A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1135US2021135A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01@mRNA-1273-P201DSmRNA-1273-P201-US202-1135US2021135A 1210 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1135US2021135A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US202-1135US2021135A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-04CmRNA-1273-P201DSmRNA-1273-P201-US202-1135US2021135AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-04CmRNA-1273-P201DSmRNA-1273-P201-US202-1136US2021136A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1136US2021136A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1137US2021137A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01pmRNA-1273-P201DSmRNA-1273-P201-US202-1137US2021137A 1278 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1137US2021137A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US202-1137US2021137A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1137US2021137AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1138US2021138A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US202-1138US2021138A 1185 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US202-1138US2021138A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B!mRNA-1273-P201DSmRNA-1273-P201-US202-1138US2021138A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US202-1138US2021138AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US202-1139US2021139A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1139US2021139A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1140US2021140A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1140US2021140A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1141US2021141A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1141US2021141A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1142US2021142A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1142US2021142A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1143US2021143A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1143US2021143A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1144US2021144A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US202-1144US2021144A 1212 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1144US2021144A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US202-1144US2021144A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1145US2021145A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02 mRNA-1273-P201DSmRNA-1273-P201-US202-1145US2021145A 1194 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US202-1145US2021145A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B$mRNA-1273-P201DSmRNA-1273-P201-US202-1145US2021145A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08C`mRNA-1273-P201DSmRNA-1273-P201-US202-1145US2021145AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08C`mRNA-1273-P201DSmRNA-1273-P201-US202-1146US2021146A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1146US2021146A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1147US2021147A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US202-1147US2021147A 1228 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1147US2021147A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US202-1147US2021147A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1147US2021147AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1148US2021148A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1148US2021148A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1149US2021149A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1149US2021149A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1150US2021150A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1150US2021150A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1151US2021151A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1151US2021151A 1281 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1151US2021151A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US202-1151US2021151A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1151US2021151AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1152US2021152A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1152US2021152A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1153US2021153A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1153US2021153A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1154US2021154A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US202-1154US2021154A 1226 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1154US2021154A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US202-1154US2021154A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1154US2021154AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US202-1155US2021155A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1155US2021155A 1289 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1155US2021155A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US202-1155US2021155A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US202-1155US2021155AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US202-1156US2021156A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1156US2021156A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1157US2021157A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1157US2021157A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1158US2021158A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1158US2021158A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1159US2021159A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1159US2021159A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1160US2021160A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1160US2021160A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1161US2021161A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1161US2021161A 1284 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1161US2021161A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US202-1161US2021161A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US202-1161US2021161AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US202-1162US2021162A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1162US2021162A FALSE POSITIVE COVID RESULT REPORTED FROM CENTRAL LAB OTHER DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1162US2021162A01262 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1162US2021162A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1162US2021162AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-18CmRNA-1273-P201DSmRNA-1273-P201-US202-1163US2021163A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1163US2021163A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1164US2021164A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1164US2021164A 1245 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1164US2021164A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US202-1164US2021164A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US202-1164US2021164AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US202-1165US2021165A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1165US2021165A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1166US2021166A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US202-1166US2021166A 1219 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US202-1166US2021166A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US202-1166US2021166A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-04-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1166US2021166AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-04-02CmRNA-1273-P201DSmRNA-1273-P201-US202-1167US2021167A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US202-1167US2021167A 1259 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1167US2021167A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US202-1167US2021167A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1167US2021167AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1168US2021168A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1168US2021168A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1169US2021169A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1169US2021169A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1170US2021170A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1170US2021170A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1171US2021171A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1171US2021171A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1172US2021172A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1172US2021172A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US202-1173US2021173A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1173US2021173A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1174US2021174A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1174US2021174A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1175US2021175A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04@mRNA-1273-P201DSmRNA-1273-P201-US202-1175US2021175A 1268 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1175US2021175A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US202-1175US2021175A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1175US2021175AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1176US2021176A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1176US2021176A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US202-1177US2021177A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1177US2021177A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1178US2021178A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1178US2021178A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1179US2021179A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US202-1179US2021179A 1272 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1179US2021179A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US202-1179US2021179A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1179US2021179AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1180US2021180A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US202-1180US2021180A 1283 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1180US2021180A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US202-1180US2021180A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1180US2021180AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1181US2021181A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1181US2021181A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1182US2021182A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US202-1182US2021182A 1249 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US202-1182US2021182A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US202-1182US2021182A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US202-1182US2021182AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US202-1183US2021183A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US202-1183US2021183A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1184US2021184A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1184US2021184A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US202-1185US2021185A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US202-1185US2021185A 2008 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1185US2021185A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B$mRNA-1273-P201DSmRNA-1273-P201-US202-1185US2021185A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US202-1185US2021185AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10C mRNA-1273-P201DSmRNA-1273-P201-US202-1186US2021186A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US202-1186US2021186A 1978 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1186US2021186A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US202-1186US2021186A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1186US2021186AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1187US2021187A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US202-1187US2021187A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US202-1188US2021188A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US202-1188US2021188A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1189US2021189A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US202-1189US2021189A 1974 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1189US2021189A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US202-1189US2021189A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1189US2021189AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1190US2021190A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US202-1190US2021190A 2013 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1190US2021190A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US202-1190US2021190A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1190US2021190AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US202-1191US2021191A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US202-1191US2021191A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US202-1192US2021192A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US202-1192US2021192A 1954 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1192US2021192A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US202-1192US2021192A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CpmRNA-1273-P201DSmRNA-1273-P201-US202-1192US2021192AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-15CpmRNA-1273-P201DSmRNA-1273-P201-US202-1193US2021193A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1193US2021193A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US202-1194US2021194A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1194US2021194A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US202-1195US2021195A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1195US2021195A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1196US2021196A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US202-1196US2021196A 2129 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1196US2021196A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US202-1196US2021196A@ REQUEST TO UNBLIND / EUA COVID-19 VACCINE PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-21BmRNA-1273-P201DSmRNA-1273-P201-US202-1197US2021197A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1197US2021197A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US202-1198US2021198A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US202-1198US2021198A 2045 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1198US2021198A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04B%mRNA-1273-P201DSmRNA-1273-P201-US202-1198US2021198A@ VACCINATION OUTSIDE OF THE STUDY AND PROTOCOL DEVIATION PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US202-1199US2021199A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US202-1199US2021199A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US202-1201US2021201A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US202-1201US2021201A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US202-1202US2021006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1202US2021006A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1202US2021202A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1202US2021202A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US202-1203US2021203A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1203US2021203A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US202-1204US2021204A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1204US2021204A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021035A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021205A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021205A@2015 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021205AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B$mRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021205A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US202-1205US2021205Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26%mRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021029A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021206A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021206A@2133 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021206AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04B"mRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021206A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22BmRNA-1273-P201DSmRNA-1273-P201-US202-1206US2021206Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22BmRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021104A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021207A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021207A@2024 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021207AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06B*mRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021207A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1207US2021207Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27#mRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021044A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021208A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021208A@2120 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021208AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021208A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1208US2021208Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1209US2021046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1209US2021046A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1209US2021209A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1209US2021209A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US202-1210US2021042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US202-1210US2021042A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1210US2021210A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1210US2021210A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26%mRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021010A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021211A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021211A@2141 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021211AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021211A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1211US2021211Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1212US2021212A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1212US2021212A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1213US2021076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US202-1213US2021076A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1213US2021213A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1213US2021213A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021040A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021214A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021214A@2016 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021214AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021214A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US202-1214US2021214Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27!mRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021070A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021215A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021215A@2051 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021215AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B$mRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021215A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1215US2021215Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27$mRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021039A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021216A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021216A@2127 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021216AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021216A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1216US2021216Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02BmRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021200A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021200A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021217A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021217A@2050 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021217AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021217A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1217US2021217Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-01-28BmRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28!mRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021106A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23pmRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021218A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23pmRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021218A@2080 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021218AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B mRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021218A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US202-1218US2021218Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26#mRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021024A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23pmRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021219A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23pmRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021219A@2076 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021219AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B mRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021219A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1219US2021219Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26"mRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021016A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24PmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021220A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24PmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021220A@2049 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021220AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021220A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US202-1220US2021220Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US202-1221US2021221A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1221US2021221A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26%mRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021023A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021222A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-290mRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021222A@2139 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021222AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021222A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1222US2021222Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US202-1223US2021223A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1223US2021223A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US202-1224US2021224A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US202-1224US2021224A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US202-1225US2021225A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US202-1225US2021225A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1226US2021226A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US202-1226US2021226A 2175 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US202-1226US2021226A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US202-1226US2021226A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US202-1226US2021226AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US202-1227US2021227A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1227US2021227A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1228US2021228A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1228US2021228A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1229US2021229A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US202-1229US2021229A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1230US2021230A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US202-1230US2021230A 2182 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US202-1230US2021230A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US202-1230US2021230A@ VACCINATION OUTSIDE OF STUDY PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US202-1231US2021231A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1231US2021231A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1232US2021232A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02@mRNA-1273-P201DSmRNA-1273-P201-US202-1232US2021232A 2176 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US202-1232US2021232A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06B mRNA-1273-P201DSmRNA-1273-P201-US202-1232US2021232A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US202-1232US2021232AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US202-1233US2021233A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US202-1233US2021233A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1234US2021234A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02PmRNA-1273-P201DSmRNA-1273-P201-US202-1234US2021234A 2195 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US202-1234US2021234A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US202-1234US2021234A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1234US2021234AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US202-1235US2021235A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1235US2021235A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1236US2021236A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1236US2021236A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1237US2021237A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1237US2021237A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1238US2021238A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1238US2021238A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1239US2021239A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1239US2021239A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US202-1240US2021240A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US202-1240US2021240A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US202-1241US2021241A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US202-1241US2021241A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1001US2031001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1001US2031001A 1013 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1001US2031001A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30B!mRNA-1273-P201DSmRNA-1273-P201-US203-1001US2031001A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1001US2031001AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1002US2031002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1002US2031002A 1001 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1002US2031002A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US203-1002US2031002A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1002US2031002AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1003US2031003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1003US2031003A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1004US2031004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1004US2031004A 1010 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1004US2031004A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US203-1004US2031004A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09CmRNA-1273-P201DSmRNA-1273-P201-US203-1004US2031004AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09CmRNA-1273-P201DSmRNA-1273-P201-US203-1005US2031005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1005US2031005A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1006US2031006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1006US2031006A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1007US2031007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1007US2031007A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1008US2031008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1008US2031008A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1009US2031009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US203-1009US2031009A 1021 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1009US2031009A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1009US2031009A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1009US2031009AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1010US2031010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1010US2031010A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US203-1011US2031011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1011US2031011A 1016 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1011US2031011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01B"mRNA-1273-P201DSmRNA-1273-P201-US203-1011US2031011A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US203-1011US2031011AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US203-1012US2031012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US203-1012US2031012A 1034 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1012US2031012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1012US2031012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1012US2031012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1013US2031013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US203-1013US2031013A 1063 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1013US2031013A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1013US2031013A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1013US2031013AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1014US2031014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1014US2031014A 1008 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1014US2031014A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US203-1014US2031014A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1014US2031014AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1015US2031015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1015US2031015A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1016US2031016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US203-1016US2031016A 1184 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1016US2031016A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1016US2031016A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1016US2031016AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1017US2031017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1017US2031017A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1018US2031018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1018US2031018A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1019US2031019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1019US2031019A 1002 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1019US2031019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B#mRNA-1273-P201DSmRNA-1273-P201-US203-1019US2031019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1019US2031019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1020US2031020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1020US2031020A 1006 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1020US2031020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01B"mRNA-1273-P201DSmRNA-1273-P201-US203-1020US2031020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1020US2031020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1021US2031021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US203-1021US2031021A 1022 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1021US2031021A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1021US2031021A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1021US2031021AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1022US2031022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1022US2031022A 1004 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1022US2031022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US203-1022US2031022A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11C0mRNA-1273-P201DSmRNA-1273-P201-US203-1022US2031022AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11C0mRNA-1273-P201DSmRNA-1273-P201-US203-1023US2031023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US203-1023US2031023A 1003 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1023US2031023A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B#mRNA-1273-P201DSmRNA-1273-P201-US203-1023US2031023A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1023US2031023AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1024US2031024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1024US2031024A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1025US2031025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1025US2031025A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1026US2031026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27 mRNA-1273-P201DSmRNA-1273-P201-US203-1026US2031026A 1014 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1026US2031026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US203-1026US2031026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09CmRNA-1273-P201DSmRNA-1273-P201-US203-1026US2031026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09CmRNA-1273-P201DSmRNA-1273-P201-US203-1027US2031027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US203-1027US2031027A 1018 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1027US2031027A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1027US2031027A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1027US2031027AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1028US2031028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1028US2031028A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1029US2031029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US203-1029US2031029A 1058 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1029US2031029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US203-1029US2031029A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1029US2031029AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1030US2031030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US203-1030US2031030A 1118 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1030US2031030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1030US2031030A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1030US2031030AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1031US2031031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1031US2031031A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1032US2031032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1032US2031032A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1033US2031033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US203-1033US2031033A 1120 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1033US2031033A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1033US2031033A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1033US2031033AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1034US2031034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1034US2031034A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1035US2031035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US203-1035US2031035A 1027 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1035US2031035A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1035US2031035A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1035US2031035AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11CmRNA-1273-P201DSmRNA-1273-P201-US203-1036US2031036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1036US2031036A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1037US2031037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US203-1037US2031037A 1057 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1037US2031037A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1037US2031037A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1037US2031037AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1038US2031038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US203-1038US2031038A 1125 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1038US2031038A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1038US2031038A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1038US2031038AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1039US2031039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1039US2031039A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1040US2031040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US203-1040US2031040A 1031 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1040US2031040A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1040US2031040A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US203-1040US2031040AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US203-1041US2031041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US203-1041US2031041A 1066 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1041US2031041A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1041US2031041A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-27CmRNA-1273-P201DSmRNA-1273-P201-US203-1041US2031041AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-27CmRNA-1273-P201DSmRNA-1273-P201-US203-1042US2031042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US203-1042US2031042A 1195 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1042US2031042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B!mRNA-1273-P201DSmRNA-1273-P201-US203-1042US2031042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1042US2031042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1043US2031043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US203-1043US2031043A 1203 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1043US2031043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1043US2031043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1043US2031043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1044US2031044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1044US2031044A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1045US2031045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US203-1045US2031045A 1071 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1045US2031045A0 LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201DSmRNA-1273-P201-US203-1045US2031045A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B*mRNA-1273-P201DSmRNA-1273-P201-US203-1046US2031046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1046US2031046A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US203-1047US2031047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US203-1047US2031047A 1032 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1047US2031047A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1047US2031047A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1047US2031047AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1048US2031048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28@mRNA-1273-P201DSmRNA-1273-P201-US203-1048US2031048A 1045 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1048US2031048A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1048US2031048A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1048US2031048AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1049US2031049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28@mRNA-1273-P201DSmRNA-1273-P201-US203-1049US2031049A 1040 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1049US2031049A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1049US2031049A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1049US2031049AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1050US2031050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US203-1050US2031050A 1129 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1050US2031050A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1050US2031050A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1050US2031050AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US203-1051US2031051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28@mRNA-1273-P201DSmRNA-1273-P201-US203-1051US2031051A 1041 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1051US2031051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1051US2031051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12CmRNA-1273-P201DSmRNA-1273-P201-US203-1051US2031051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12CmRNA-1273-P201DSmRNA-1273-P201-US203-1052US2031052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1052US2031052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US203-1053US2031053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1053US2031053A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1054US2031054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1054US2031054A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1055US2031055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1055US2031055A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1056US2031056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28@mRNA-1273-P201DSmRNA-1273-P201-US203-1056US2031056A 1038 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1056US2031056A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1056US2031056A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US203-1056US2031056AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US203-1057US2031057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US203-1057US2031057A 1130 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1057US2031057A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1057US2031057A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1057US2031057AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1058US2031058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28@mRNA-1273-P201DSmRNA-1273-P201-US203-1058US2031058A 1042 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1058US2031058A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US203-1058US2031058A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1058US2031058AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1059US2031059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1059US2031059A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1060US2031060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US203-1060US2031060A 1199 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1060US2031060A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1060US2031060A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1060US2031060AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1061US2031061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1061US2031061A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US203-1062US2031062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US203-1062US2031062A 1201 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1062US2031062A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1062US2031062A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1062US2031062AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1063US2031063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US203-1063US2031063A 1110 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1063US2031063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1063US2031063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1063US2031063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1064US2031064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1064US2031064A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1065US2031065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1065US2031065A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US203-1066US2031066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US203-1066US2031066A 1065 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1066US2031066A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1066US2031066A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1066US2031066AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1067US2031067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1067US2031067A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US203-1068US2031068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1068US2031068A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1069US2031069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1069US2031069A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1070US2031070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1070US2031070A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1071US2031071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29`mRNA-1273-P201DSmRNA-1273-P201-US203-1071US2031071A 1202 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1071US2031071A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1071US2031071A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1071US2031071AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1072US2031072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US203-1072US2031072A 1137 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US203-1072US2031072A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US203-1072US2031072A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1072US2031072AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1073US2031073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US203-1073US2031073A 1079 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1073US2031073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1073US2031073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US203-1073US2031073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US203-1074US2031074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US203-1074US2031074A 1111 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1074US2031074A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1074US2031074A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1074US2031074AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1075US2031075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1075US2031075A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US203-1076US2031076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1076US2031076A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US203-1077US2031077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1077US2031077A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US203-1078US2031078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1078US2031078A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US203-1079US2031079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02 mRNA-1273-P201DSmRNA-1273-P201-US203-1079US2031079A 1197 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1079US2031079A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1079US2031079A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03CmRNA-1273-P201DSmRNA-1273-P201-US203-1079US2031079AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03CmRNA-1273-P201DSmRNA-1273-P201-US203-1080US2031080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02 mRNA-1273-P201DSmRNA-1273-P201-US203-1080US2031080A 1190 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1080US2031080A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1080US2031080A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US203-1080US2031080AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US203-1081US2031081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02 mRNA-1273-P201DSmRNA-1273-P201-US203-1081US2031081A 1181 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US203-1081US2031081A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1081US2031081A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1081US2031081AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1082US2031082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US203-1082US2031082A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1083US2031083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US203-1083US2031083A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US203-1084US2031084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05PmRNA-1273-P201DSmRNA-1273-P201-US203-1084US2031084A 1300 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-10AmRNA-1273-P201DSmRNA-1273-P201-US203-1084US2031084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US203-1084US2031084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1084US2031084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1085US2031085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1085US2031085A 1959 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1085US2031085A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US203-1085US2031085A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1085US2031085AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1086US2031086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1086US2031086A 1957 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1086US2031086A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1086US2031086A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1086US2031086AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1087US2031087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1087US2031087A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1088US2031088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1088US2031088A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1089US2031089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1089US2031089A 1980 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1089US2031089A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US203-1089US2031089A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1089US2031089AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1090US2031090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1090US2031090A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1091US2031091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1091US2031091A 1985 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1091US2031091A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1091US2031091A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1091US2031091AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1092US2031092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1092US2031092A 2086 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US203-1092US2031092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1092US2031092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1092US2031092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1093US2031093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US203-1093US2031093A 2123 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1093US2031093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US203-1093US2031093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1093US2031093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1095US2031095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1095US2031095A 2041 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1095US2031095A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US203-1095US2031095A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US203-1095US2031095AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US203-1096US2031096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1096US2031096A 1981 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1096US2031096A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1096US2031096A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1096US2031096AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1097US2031097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1097US2031097A 2087 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US203-1097US2031097A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B#mRNA-1273-P201DSmRNA-1273-P201-US203-1097US2031097A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1097US2031097AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1098US2031098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1098US2031098A 2056 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1098US2031098A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1098US2031098A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1098US2031098AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1099US2031099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1099US2031099A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US203-1100US2031100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1100US2031100A 2122 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1100US2031100A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B"mRNA-1273-P201DSmRNA-1273-P201-US203-1100US2031100A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1100US2031100AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1101US2031101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1101US2031101A 2057 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1101US2031101A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B$mRNA-1273-P201DSmRNA-1273-P201-US203-1101US2031101A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US203-1101US2031101AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US203-1102US2031102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1102US2031102A 2153 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1102US2031102A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US203-1102US2031102A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1102US2031102AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1103US2031103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US203-1103US2031103A 2060 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1103US2031103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30B mRNA-1273-P201DSmRNA-1273-P201-US203-1103US2031103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1103US2031103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US203-1104US2031104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1104US2031104A 1956 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1104US2031104A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B$mRNA-1273-P201DSmRNA-1273-P201-US203-1104US2031104A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1104US2031104AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1105US2031105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1105US2031105A 1963 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1105US2031105A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US203-1105US2031105A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1105US2031105AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1106US2031106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1106US2031106A 2002 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1106US2031106A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US203-1106US2031106A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US203-1106US2031106AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US203-1107US2031107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1107US2031107A 2039 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1107US2031107A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US203-1107US2031107A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1107US2031107AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1108US2031108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1108US2031108A 2180 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US203-1108US2031108A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US203-1108US2031108A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1108US2031108AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1109US2031109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1109US2031109A 2006 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1109US2031109A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1109US2031109A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1109US2031109AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1110US2031110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1110US2031110A 2005 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1110US2031110A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US203-1110US2031110A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1110US2031110AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US203-1111US2031111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1111US2031111A 2003 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1111US2031111A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1111US2031111A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1111US2031111AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US203-1112US2031112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US203-1112US2031112A 1979 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1112US2031112A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US203-1112US2031112A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1112US2031112AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1113US2031113A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1113US2031113A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1114US2031114A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US203-1114US2031114A 2115 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1114US2031114A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1114US2031114A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US203-1114US2031114AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US203-1115US2031115A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1115US2031115A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US203-1116US2031116A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US203-1116US2031116A 2040 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1116US2031116A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30B mRNA-1273-P201DSmRNA-1273-P201-US203-1116US2031116A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1116US2031116AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1117US2031117A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1117US2031117A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US203-1118US2031118A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1118US2031118A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1119US2031119A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1119US2031119A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US203-1120US2031120A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1120US2031120A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US203-1121US2031121A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US203-1121US2031121A 2094 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US203-1121US2031121A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US203-1121US2031121A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1121US2031121AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1122US2031122A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US203-1122US2031122A 2061 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1122US2031122A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1122US2031122A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1122US2031122AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1123US2031123A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US203-1123US2031123A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US203-1124US2031124A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US203-1124US2031124A 2071 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US203-1124US2031124A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1124US2031124A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1124US2031124AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US203-1125US2031125A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19pmRNA-1273-P201DSmRNA-1273-P201-US203-1125US2031125A 1990 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US203-1125US2031125A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US203-1125US2031125A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1125US2031125AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1126US2031126A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US203-1126US2031126A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US203-1127US2031094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1127US2031094A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US203-1127US2031127A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US203-1127US2031127A@ INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US203-1128US2031128A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US203-1128US2031128A 2117 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1128US2031128A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US203-1128US2031128A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1128US2031128AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-13BmRNA-1273-P201DSmRNA-1273-P201-US203-1129US2031129A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25`mRNA-1273-P201DSmRNA-1273-P201-US203-1129US2031129A 2116 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US203-1129US2031129A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US203-1129US2031129A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1129US2031129AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US203-1130US2031130A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US203-1130US2031130A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US203-1131US2031131A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-290mRNA-1273-P201DSmRNA-1273-P201-US203-1131US2031131A 2145 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US203-1131US2031131A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US203-1131US2031131A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US203-1131US2031131AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US203-1132US2031132A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US203-1132US2031132A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US203-1133US2031133A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US203-1133US2031133A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US203-1134US2031134A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US203-1134US2031134A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US203-1135US2031135A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US203-1135US2031135A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US203-1136US2031136A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US203-1136US2031136A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1001US2041001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1001US2041001A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US204-1002US2041002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1002US2041002A 1078 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1002US2041002A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1002US2041002A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1002US2041002AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1003US2041003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1003US2041003A 1102 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1003US2041003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1003US2041003A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-04-27CmRNA-1273-P201DSmRNA-1273-P201-US204-1003US2041003AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-04-27CmRNA-1273-P201DSmRNA-1273-P201-US204-1004US2041004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1004US2041004A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1005US2041005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US204-1005US2041005A 1009 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1005US2041005A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US204-1005US2041005A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US204-1005US2041005AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-08CmRNA-1273-P201DSmRNA-1273-P201-US204-1006US2041006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1006US2041006A 1072 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1006US2041006A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US204-1006US2041006A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1006US2041006AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1007US2041007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US204-1007US2041007A 1025 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1007US2041007A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US204-1007US2041007A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US204-1007US2041007AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US204-1008US2041008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US204-1008US2041008A 1037 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1008US2041008A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1008US2041008A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1008US2041008AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1009US2041009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1009US2041009A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1010US2041010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US204-1010US2041010A 1011 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1010US2041010A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US204-1010US2041010A@ SUBJECT RECEIVED A COVID VACCINE THROUGH THEIR WORKPLACE. PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1011US2041011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US204-1011US2041011A 1030 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1011US2041011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1011US2041011A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1011US2041011AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1012US2041012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1012US2041012A 1055 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1012US2041012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US204-1012US2041012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1012US2041012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1013US2041013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US204-1013US2041013A 1017 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1013US2041013A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US204-1013US2041013A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CmRNA-1273-P201DSmRNA-1273-P201-US204-1013US2041013AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CmRNA-1273-P201DSmRNA-1273-P201-US204-1014US2041014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US204-1014US2041014A 1015 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1014US2041014A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-26BmRNA-1273-P201DSmRNA-1273-P201-US204-1014US2041014A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US204-1014US2041014AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US204-1015US2041015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1015US2041015A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1016US2041016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1016US2041016A 1108 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1016US2041016A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-14B+mRNA-1273-P201DSmRNA-1273-P201-US204-1016US2041016A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1016US2041016AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1017US2041017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1017US2041017A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1018US2041018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1018US2041018A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1019US2041019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US204-1019US2041019A 1098 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1019US2041019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1019US2041019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1019US2041019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1020US2041020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US204-1020US2041020A 1155 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1020US2041020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1020US2041020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19C`mRNA-1273-P201DSmRNA-1273-P201-US204-1020US2041020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19C`mRNA-1273-P201DSmRNA-1273-P201-US204-1021US2041021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1021US2041021A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1022US2041022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US204-1022US2041022A 1221 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US204-1022US2041022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US204-1022US2041022A@ SUBJECT RECIEVED A VACCINATION FROM THEIR PLACE FO WORK PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US204-1023US2041023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1023US2041023A 1043 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1023US2041023A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US204-1023US2041023A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C`mRNA-1273-P201DSmRNA-1273-P201-US204-1023US2041023AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C`mRNA-1273-P201DSmRNA-1273-P201-US204-1024US2041024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US204-1024US2041024A 1152 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1024US2041024A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US204-1024US2041024A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C mRNA-1273-P201DSmRNA-1273-P201-US204-1024US2041024AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C mRNA-1273-P201DSmRNA-1273-P201-US204-1025US2041025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US204-1025US2041025A 1053 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1025US2041025A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1025US2041025A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1025US2041025AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1026US2041026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US204-1026US2041026A 1070 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1026US2041026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1026US2041026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1026US2041026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1027US2041027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1027US2041027A 1029 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1027US2041027A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US204-1027US2041027A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CPmRNA-1273-P201DSmRNA-1273-P201-US204-1027US2041027AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CPmRNA-1273-P201DSmRNA-1273-P201-US204-1028US2041028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1028US2041028A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US204-1029US2041029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1029US2041029A 1028 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1029US2041029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US204-1029US2041029A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1029US2041029AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1030US2041030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1030US2041030A 1036 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1030US2041030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1030US2041030A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US204-1030US2041030AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CpmRNA-1273-P201DSmRNA-1273-P201-US204-1031US2041031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1031US2041031A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1032US2041032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1032US2041032A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1033US2041033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1033US2041033A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1034US2041034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1034US2041034A 1033 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1034US2041034A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B mRNA-1273-P201DSmRNA-1273-P201-US204-1034US2041034A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1034US2041034AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1035US2041035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1035US2041035A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US204-1036US2041036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US204-1036US2041036A 1050 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1036US2041036A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1036US2041036A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1036US2041036AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1037US2041037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1037US2041037A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1038US2041038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1038US2041038A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1039US2041039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1039US2041039A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US204-1040US2041040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1040US2041040A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US204-1041US2041041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1041US2041041A 1048 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1041US2041041A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B$mRNA-1273-P201DSmRNA-1273-P201-US204-1041US2041041A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1041US2041041AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1042US2041042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US204-1042US2041042A 1046 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1042US2041042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B$mRNA-1273-P201DSmRNA-1273-P201-US204-1042US2041042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1042US2041042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US204-1043US2041043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US204-1043US2041043A 1160 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1043US2041043A0 LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1043US2041043A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1044US2041044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1044US2041044A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1045US2041045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1045US2041045A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1046US2041046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US204-1046US2041046A 1186 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US204-1046US2041046A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US204-1046US2041046A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US204-1046US2041046AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US204-1047US2041047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1047US2041047A 1054 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1047US2041047A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1047US2041047A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1047US2041047AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1048US2041048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1048US2041048A 1077 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1048US2041048A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1048US2041048A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1048US2041048AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1049US2041049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US204-1049US2041049A 1191 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US204-1049US2041049A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-14B)mRNA-1273-P201DSmRNA-1273-P201-US204-1049US2041049A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C@mRNA-1273-P201DSmRNA-1273-P201-US204-1049US2041049AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C@mRNA-1273-P201DSmRNA-1273-P201-US204-1050US2041050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1050US2041050A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1051US2041051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1051US2041051A 1094 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1051US2041051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1051US2041051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1051US2041051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1052US2041052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1052US2041052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US204-1053US2041053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1053US2041053A 1088 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1053US2041053A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US204-1053US2041053A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1053US2041053AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US204-1054US2041054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1054US2041054A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1055US2041055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US204-1055US2041055A 1131 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1055US2041055A0 LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1055US2041055A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1056US2041056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1056US2041056A 1093 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1056US2041056A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1056US2041056A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1056US2041056AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US204-1057US2041057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1057US2041057A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US204-1058US2041058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US204-1058US2041058A 1143 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1058US2041058A0 LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1058US2041058A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-17B-mRNA-1273-P201DSmRNA-1273-P201-US204-1059US2041059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1059US2041059A 1103 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1059US2041059A0 LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-27B8mRNA-1273-P201DSmRNA-1273-P201-US204-1059US2041059A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B8mRNA-1273-P201DSmRNA-1273-P201-US204-1060US2041060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1060US2041060A 1064 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1060US2041060A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1060US2041060A@ (b)(6) WITHDRAWAL BY SUBJECT DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-05-27CmRNA-1273-P201DSmRNA-1273-P201-US204-1061US2041061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1061US2041061A 1107 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1061US2041061A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US204-1061US2041061A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1061US2041061AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1062US2041062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US204-1062US2041062A 1083 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1062US2041062A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1062US2041062A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1062US2041062AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1063US2041063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1063US2041063A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1064US2041064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US204-1064US2041064A 1290 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1064US2041064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-14B%mRNA-1273-P201DSmRNA-1273-P201-US204-1064US2041064A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-08-18BHmRNA-1273-P201DSmRNA-1273-P201-US204-1065US2041065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1065US2041065A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1066US2041066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1066US2041066A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1067US2041067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1067US2041067A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1068US2041068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US204-1068US2041068A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1069US2041069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1069US2041069A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1070US2041070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1070US2041070A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US204-1071US2041071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US204-1071US2041071A 1115 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1071US2041071A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US204-1071US2041071A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US204-1071US2041071AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US204-1072US2041072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1072US2041072A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1073US2041073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US204-1073US2041073A 1114 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1073US2041073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US204-1073US2041073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1073US2041073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1074US2041074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1074US2041074A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1075US2041075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US204-1075US2041075A 1085 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1075US2041075A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1075US2041075A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1075US2041075AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US204-1076US2041076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US204-1076US2041076A 1084 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1076US2041076A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US204-1076US2041076A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1076US2041076AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US204-1077US2041077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US204-1077US2041077A 1147 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1077US2041077A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1077US2041077A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-05-14CmRNA-1273-P201DSmRNA-1273-P201-US204-1078US2041078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US204-1078US2041078A 1148 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1078US2041078A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1078US2041078A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-22CPmRNA-1273-P201DSmRNA-1273-P201-US204-1078US2041078AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-22CPmRNA-1273-P201DSmRNA-1273-P201-US204-1079US2041079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US204-1079US2041079A 1161 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1079US2041079A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US204-1079US2041079A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CPmRNA-1273-P201DSmRNA-1273-P201-US204-1079US2041079AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CPmRNA-1273-P201DSmRNA-1273-P201-US204-1080US2041080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US204-1080US2041080A 1163 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US204-1080US2041080A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US204-1080US2041080A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US204-1080US2041080AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US204-1081US2041081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1081US2041081A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1082US2041082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1082US2041082A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1083US2041083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1083US2041083A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1084US2041084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US204-1084US2041084A 1183 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US204-1084US2041084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US204-1084US2041084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C0mRNA-1273-P201DSmRNA-1273-P201-US204-1084US2041084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C0mRNA-1273-P201DSmRNA-1273-P201-US204-1085US2041085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US204-1085US2041085A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1086US2041086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US204-1086US2041086A 1253 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1086US2041086A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06BmRNA-1273-P201DSmRNA-1273-P201-US204-1086US2041086A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-12-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1087US2041087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US204-1087US2041087A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1088US2041088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US204-1088US2041088A 1277 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1088US2041088A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B!mRNA-1273-P201DSmRNA-1273-P201-US204-1088US2041088A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1088US2041088AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1089US2041089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US204-1089US2041089A 1252 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1089US2041089A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B!mRNA-1273-P201DSmRNA-1273-P201-US204-1089US2041089A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1089US2041089AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1090US2041090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US204-1090US2041090A 1282 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1090US2041090A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B!mRNA-1273-P201DSmRNA-1273-P201-US204-1090US2041090A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1090US2041090AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1091US2041091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05PmRNA-1273-P201DSmRNA-1273-P201-US204-1091US2041091A 1298 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-10AmRNA-1273-P201DSmRNA-1273-P201-US204-1091US2041091A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10BmRNA-1273-P201DSmRNA-1273-P201-US204-1091US2041091A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1091US2041091AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1092US2041092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US204-1092US2041092A 1286 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US204-1092US2041092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-14B%mRNA-1273-P201DSmRNA-1273-P201-US204-1092US2041092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1092US2041092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1093US2041093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1093US2041093A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1094US2041094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-08mRNA-1273-P201DSmRNA-1273-P201-US204-1094US2041094A 2007 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1094US2041094A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1094US2041094A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1094US2041094AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1095US2041095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US204-1095US2041095A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US204-1096US2041096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US204-1096US2041096A 2037 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1096US2041096A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1096US2041096A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1096US2041096AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1097US2041097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US204-1097US2041097A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1098US2041098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US204-1098US2041098A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1099US2041099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US204-1099US2041099A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1100US2041100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US204-1100US2041100A 2038 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1100US2041100A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1100US2041100A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1100US2041100AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1101US2041101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1101US2041101A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US204-1102US2041102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US204-1102US2041102A 1953 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1102US2041102A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1102US2041102A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1102US2041102AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1103US2041103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US204-1103US2041103A 1991 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1103US2041103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1103US2041103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1103US2041103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1104US2041104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US204-1104US2041104A 1992 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1104US2041104A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1104US2041104A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1104US2041104AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1105US2041105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US204-1105US2041105A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1106US2041106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1106US2041106A 2029 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1106US2041106A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US204-1106US2041106A@ SUBJECT WITHDREW CONSENT. WITHDRAWAL BY SUBJECT DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-04-19CmRNA-1273-P201DSmRNA-1273-P201-US204-1107US2041107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1107US2041107A 2033 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1107US2041107A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US204-1107US2041107A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1107US2041107AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1108US2041108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1108US2041108A 1962 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1108US2041108A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US204-1108US2041108A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1108US2041108AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1109US2041109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1109US2041109A 1984 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1109US2041109A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US204-1109US2041109A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1109US2041109AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1110US2041110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US204-1110US2041110A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US204-1111US2041111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1111US2041111A 2053 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1111US2041111A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US204-1111US2041111A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1111US2041111AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1112US2041112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1112US2041112A 2004 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1112US2041112A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US204-1112US2041112A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1112US2041112AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1113US2041113A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1113US2041113A 2079 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US204-1113US2041113A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1113US2041113A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1113US2041113AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1114US2041114A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1114US2041114A 2028 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1114US2041114A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B'mRNA-1273-P201DSmRNA-1273-P201-US204-1114US2041114A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1114US2041114AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1115US2041115A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1115US2041115A 2114 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1115US2041115A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04B#mRNA-1273-P201DSmRNA-1273-P201-US204-1115US2041115A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-04-13CmRNA-1273-P201DSmRNA-1273-P201-US204-1115US2041115AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-04-13CmRNA-1273-P201DSmRNA-1273-P201-US204-1116US2041116A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US204-1116US2041116A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1117US2041117A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1117US2041117A 2025 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1117US2041117A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US204-1117US2041117A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1117US2041117AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1118US2041118A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1118US2041118A 2072 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1118US2041118A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1118US2041118A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1118US2041118AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1119US2041119A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1119US2041119A 2177 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US204-1119US2041119A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US204-1119US2041119A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1119US2041119AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1120US2041120A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US204-1120US2041120A 2095 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US204-1120US2041120A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1120US2041120A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1120US2041120AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1121US2041121A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1121US2041121A 2121 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1121US2041121A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US204-1121US2041121A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1121US2041121AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1122US2041122A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1122US2041122A 2042 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1122US2041122A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US204-1122US2041122A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1122US2041122AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1123US2041123A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1123US2041123A 1969 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1123US2041123A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1123US2041123A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1123US2041123AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1124US2041124A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US204-1124US2041124A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US204-1125US2041125A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1125US2041125A 2069 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1125US2041125A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1125US2041125A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1125US2041125AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1126US2041126A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1126US2041126A 2000 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1126US2041126A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US204-1126US2041126A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1126US2041126AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1127US2041127A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US204-1127US2041127A 1998 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1127US2041127A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1127US2041127A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US204-1127US2041127AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-11C0mRNA-1273-P201DSmRNA-1273-P201-US204-1128US2041128A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US204-1128US2041128A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US204-1129US2041129A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1129US2041129A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US204-1130US2041130A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US204-1130US2041130A 2026 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1130US2041130A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1130US2041130A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1130US2041130AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1131US2041131A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US204-1131US2041131A 2066 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1131US2041131A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B+mRNA-1273-P201DSmRNA-1273-P201-US204-1131US2041131A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1131US2041131AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1132US2041132A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US204-1132US2041132A 1960 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1132US2041132A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US204-1132US2041132A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1132US2041132AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1133US2041133A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1133US2041133A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US204-1134US2041134A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1134US2041134A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US204-1135US2041135A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1135US2041135A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1136US2041136A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US204-1136US2041136A 2111 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1136US2041136A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B"mRNA-1273-P201DSmRNA-1273-P201-US204-1136US2041136A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1136US2041136AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1137US2041137A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US204-1137US2041137A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1138US2041138A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US204-1138US2041138A 2021 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1138US2041138A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US204-1138US2041138A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1138US2041138AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1139US2041139A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US204-1139US2041139A 2065 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US204-1139US2041139A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US204-1139US2041139A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1139US2041139AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US204-1140US2041140A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US204-1140US2041140A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1141US2041141A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US204-1141US2041141A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1142US2041142A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US204-1142US2041142A 2150 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1142US2041142A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US204-1142US2041142A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1142US2041142AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1143US2041143A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US204-1143US2041143A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US204-1144US2041144A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US204-1144US2041144A 2018 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US204-1144US2041144A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US204-1144US2041144A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1144US2041144AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1145US2041145A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US204-1145US2041145A 2151 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1145US2041145A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US204-1145US2041145A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1145US2041145AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1146US2041146A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US204-1146US2041146A 2154 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US204-1146US2041146A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US204-1146US2041146A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1146US2041146AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US204-1147US2041147A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US204-1147US2041147A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1148US2041148A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US204-1148US2041148A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US204-1149US2041149A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US204-1149US2041149A 2189 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US204-1149US2041149A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US204-1149US2041149A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1149US2041149AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1150US2041150A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US204-1150US2041150A 2110 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US204-1150US2041150A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B"mRNA-1273-P201DSmRNA-1273-P201-US204-1150US2041150A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1150US2041150AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US204-1151US2041151A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US204-1151US2041151A 2184 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US204-1151US2041151A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US204-1151US2041151A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1151US2041151AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US204-1152US2041152A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US204-1152US2041152A 2199 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US204-1152US2041152A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US204-1152US2041152A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US204-1152US2041152AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US204-1153US2041153A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US204-1153US2041153A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1154US2041154A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US204-1154US2041154A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1155US2041155A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29pmRNA-1273-P201DSmRNA-1273-P201-US204-1155US2041155A 2186 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US204-1155US2041155A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US204-1155US2041155A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1155US2041155AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1156US2041156A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1156US2041156A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1157US2041157A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US204-1157US2041157A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1158US2041158A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US204-1158US2041158A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1159US2041159A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US204-1159US2041159A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US204-1160US2041160A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US204-1160US2041160A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1161US2041161A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1161US2041161A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1162US2041162A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1162US2041162A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1163US2041163A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1163US2041163A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1164US2041164A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1164US2041164A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1165US2041165A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1165US2041165A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1166US2041166A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US204-1166US2041166A 2181 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US204-1166US2041166A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US204-1166US2041166A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1166US2041166AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US204-1167US2041167A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1167US2041167A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US204-1168US2041168A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US204-1168US2041168A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1169US2041169A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US204-1169US2041169A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1170US2041170A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US204-1170US2041170A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US204-1171US2041171A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US204-1171US2041171A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US204-1172US2041172A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US204-1172US2041172A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-07.mRNA-1273-P201DSmRNA-1273-P201-US205-1001US2051001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US205-1001US2051001A 1172 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1001US2051001A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1001US2051001A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C@mRNA-1273-P201DSmRNA-1273-P201-US205-1001US2051001AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C@mRNA-1273-P201DSmRNA-1273-P201-US205-1002US2051002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26pmRNA-1273-P201DSmRNA-1273-P201-US205-1002US2051002A 1089 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1002US2051002A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1002US2051002A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1002US2051002AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1003US2051003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US205-1003US2051003A 1007 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US205-1003US2051003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-23BmRNA-1273-P201DSmRNA-1273-P201-US205-1003US2051003A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-11-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1004US2051004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US205-1004US2051004A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US205-1005US2051005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US205-1005US2051005A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US205-1006US2051006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US205-1006US2051006A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US205-1007US2051007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US205-1007US2051007A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US205-1008US2051008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US205-1008US2051008A 1005 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US205-1008US2051008A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30B!mRNA-1273-P201DSmRNA-1273-P201-US205-1008US2051008A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12C@mRNA-1273-P201DSmRNA-1273-P201-US205-1008US2051008AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12C@mRNA-1273-P201DSmRNA-1273-P201-US205-1009US2051009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US205-1009US2051009A 1069 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1009US2051009A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1009US2051009A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US205-1009US2051009AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US205-1010US2051010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US205-1010US2051010A 1092 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1010US2051010A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1010US2051010A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US205-1010US2051010AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US205-1011US2051011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US205-1011US2051011A 1138 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1011US2051011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US205-1011US2051011A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1011US2051011AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1012US2051012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US205-1012US2051012A 1095 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1012US2051012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US205-1012US2051012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1012US2051012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1013US2051013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US205-1013US2051013A 1135 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1013US2051013A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US205-1013US2051013A@ SUBJECT MOVED OUT OF STATE WITHDRAWAL BY SUBJECT DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-10CmRNA-1273-P201DSmRNA-1273-P201-US205-1014US2051014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US205-1014US2051014A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1015US2051015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US205-1015US2051015A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US205-1016US2051016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US205-1016US2051016A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1017US2051017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US205-1017US2051017A 1227 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US205-1017US2051017A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US205-1017US2051017A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CpmRNA-1273-P201DSmRNA-1273-P201-US205-1017US2051017AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CpmRNA-1273-P201DSmRNA-1273-P201-US205-1018US2051018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US205-1018US2051018A 1250 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US205-1018US2051018A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US205-1018US2051018A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1018US2051018AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1019US2051019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US205-1019US2051019A 1294 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-09AmRNA-1273-P201DSmRNA-1273-P201-US205-1019US2051019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US205-1019US2051019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1019US2051019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1020US2051020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US205-1020US2051020A 1179 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1020US2051020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1020US2051020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-01CmRNA-1273-P201DSmRNA-1273-P201-US205-1020US2051020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-01CmRNA-1273-P201DSmRNA-1273-P201-US205-1021US2051021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US205-1021US2051021A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US205-1022US2051022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US205-1022US2051022A 1117 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1022US2051022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US205-1022US2051022A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US205-1022US2051022AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US205-1023US2051023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US205-1023US2051023A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US205-1024US2051024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27`mRNA-1273-P201DSmRNA-1273-P201-US205-1024US2051024A 1073 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1024US2051024A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US205-1024US2051024A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1024US2051024AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1025US2051025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US205-1025US2051025A 1217 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US205-1025US2051025A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B#mRNA-1273-P201DSmRNA-1273-P201-US205-1025US2051025A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US205-1025US2051025AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16CmRNA-1273-P201DSmRNA-1273-P201-US205-1026US2051026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US205-1026US2051026A 1068 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1026US2051026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1026US2051026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US205-1026US2051026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US205-1027US2051027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US205-1027US2051027A 1266 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US205-1027US2051027A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US205-1027US2051027A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US205-1027US2051027AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18CmRNA-1273-P201DSmRNA-1273-P201-US205-1028US2051028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US205-1028US2051028A 1188 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1028US2051028A0 FALSE POSITIVE COVID INFECTION RESULTED BY CENTRAL LAB OTHER DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-15AmRNA-1273-P201DSmRNA-1273-P201-US205-1028US2051028A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US205-1028US2051028AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CPmRNA-1273-P201DSmRNA-1273-P201-US205-1029US2051029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US205-1029US2051029A 1177 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1029US2051029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B$mRNA-1273-P201DSmRNA-1273-P201-US205-1029US2051029A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1029US2051029AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1030US2051030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US205-1030US2051030A 1124 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1030US2051030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US205-1030US2051030A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1030US2051030AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1031US2051031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US205-1031US2051031A 1100 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1031US2051031A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1031US2051031A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US205-1031US2051031AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US205-1032US2051032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US205-1032US2051032A 1075 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1032US2051032A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1032US2051032A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US205-1032US2051032AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C@mRNA-1273-P201DSmRNA-1273-P201-US205-1033US2051033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US205-1033US2051033A 1193 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1033US2051033A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US205-1033US2051033A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C mRNA-1273-P201DSmRNA-1273-P201-US205-1033US2051033AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C mRNA-1273-P201DSmRNA-1273-P201-US205-1034US2051034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US205-1034US2051034A 1121 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1034US2051034A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US205-1034US2051034A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1034US2051034AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1035US2051035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US205-1035US2051035A 1173 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US205-1035US2051035A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B#mRNA-1273-P201DSmRNA-1273-P201-US205-1035US2051035A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US205-1035US2051035AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US205-1036US2051036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US205-1036US2051036A 1099 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1036US2051036A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1036US2051036A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US205-1036US2051036AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C`mRNA-1273-P201DSmRNA-1273-P201-US205-1037US2051037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1037US2051037A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1038US2051038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US205-1038US2051038A 1156 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1038US2051038A0 PATIENT WITHDREW FROM STUDY- DID NOT WANT TO PROCEED. WITHDRAWAL COVID DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1038US2051038A@ DID NOT WANT TO PROCEED- PATIENT WITHDREW FROM STUDY WITHDRAWAL COVID DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US205-1039US2051039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1039US2051039A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US205-1040US2051040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29pmRNA-1273-P201DSmRNA-1273-P201-US205-1040US2051040A 1231 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US205-1040US2051040A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US205-1040US2051040A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US205-1040US2051040AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18C0mRNA-1273-P201DSmRNA-1273-P201-US205-1041US2051041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1041US2051041A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US205-1042US2051042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US205-1042US2051042A 1081 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1042US2051042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US205-1042US2051042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1042US2051042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US205-1043US2051043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US205-1043US2051043A 1140 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US205-1043US2051043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US205-1043US2051043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1043US2051043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16C0mRNA-1273-P201DSmRNA-1273-P201-US205-1044US2051044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US205-1044US2051044A 1229 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US205-1044US2051044A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US205-1044US2051044A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1044US2051044AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1045US2051045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03pmRNA-1273-P201DSmRNA-1273-P201-US205-1045US2051045A 1299 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-10AmRNA-1273-P201DSmRNA-1273-P201-US205-1045US2051045A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1045US2051045A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1046US2051046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US205-1046US2051046A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US205-1047US2051047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US205-1047US2051047A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1048US2051048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03`mRNA-1273-P201DSmRNA-1273-P201-US205-1048US2051048A 1295 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-09AmRNA-1273-P201DSmRNA-1273-P201-US205-1048US2051048A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B mRNA-1273-P201DSmRNA-1273-P201-US205-1048US2051048A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1048US2051048AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1049US2051049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US205-1049US2051049A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1050US2051050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04@mRNA-1273-P201DSmRNA-1273-P201-US205-1050US2051050A 1279 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US205-1050US2051050A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1050US2051050A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-22C@mRNA-1273-P201DSmRNA-1273-P201-US205-1050US2051050AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22C@mRNA-1273-P201DSmRNA-1273-P201-US205-1051US2051051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US205-1051US2051051A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1052US2051052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US205-1052US2051052A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1053US2051053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1053US2051053A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US205-1054US2051054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US205-1054US2051054A 1987 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1054US2051054A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US205-1054US2051054A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1054US2051054AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1055US2051055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US205-1055US2051055A 1972 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1055US2051055A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30B#mRNA-1273-P201DSmRNA-1273-P201-US205-1055US2051055A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US205-1055US2051055AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US205-1056US2051056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US205-1056US2051056A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US205-1057US2051057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US205-1057US2051057A 1970 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1057US2051057A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US205-1057US2051057A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1057US2051057AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1058US2051058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US205-1058US2051058A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US205-1059US2051059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US205-1059US2051059A 2019 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1059US2051059A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US205-1059US2051059A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1059US2051059AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1060US2051060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US205-1060US2051060A 1977 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1060US2051060A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US205-1060US2051060A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1060US2051060AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1061US2051061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US205-1061US2051061A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US205-1062US2051062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US205-1062US2051062A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US205-1063US2051063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US205-1063US2051063A 2093 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1063US2051063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US205-1063US2051063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1063US2051063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1064US2051064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US205-1064US2051064A 2106 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US205-1064US2051064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US205-1064US2051064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1064US2051064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1065US2051065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US205-1065US2051065A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US205-1066US2051066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US205-1066US2051066A 2044 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US205-1066US2051066A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US205-1066US2051066A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1066US2051066AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1067US2051067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US205-1067US2051067A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US205-1068US2051068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US205-1068US2051068A 2091 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1068US2051068A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US205-1068US2051068A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1068US2051068AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1069US2051069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US205-1069US2051069A 2010 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US205-1069US2051069A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US205-1069US2051069A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US205-1069US2051069AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US205-1070US2051070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US205-1070US2051070A 2105 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US205-1070US2051070A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B"mRNA-1273-P201DSmRNA-1273-P201-US205-1070US2051070A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1070US2051070AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US205-1071US2051071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US205-1071US2051071A 2059 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US205-1071US2051071A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US205-1071US2051071A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1071US2051071AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1072US2051072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US205-1072US2051072A 2191 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1072US2051072A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1072US2051072A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1072US2051072AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1073US2051073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US205-1073US2051073A 2174 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1073US2051073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-05BmRNA-1273-P201DSmRNA-1273-P201-US205-1073US2051073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1073US2051073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1074US2051074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US205-1074US2051074A 2078 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1074US2051074A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US205-1074US2051074A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1074US2051074AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1075US2051075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US205-1075US2051075A 2098 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1075US2051075A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US205-1075US2051075A@ WILL RECEIVE VACCINE AT HER JOB ON 01/19/2021 WITHDRAWAL BY SUBJECT DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-11BmRNA-1273-P201DSmRNA-1273-P201-US205-1076US2051076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US205-1076US2051076A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US205-1077US2051077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US205-1077US2051077A 2083 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1077US2051077A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US205-1077US2051077A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1077US2051077AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1078US2051078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US205-1078US2051078A 2097 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1078US2051078A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US205-1078US2051078A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1078US2051078AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1079US2051079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US205-1079US2051079A ENROLLMENT CLOSED OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US205-1080US2051080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US205-1080US2051080A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1081US2051081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23`mRNA-1273-P201DSmRNA-1273-P201-US205-1081US2051081A 2055 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US205-1081US2051081A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US205-1081US2051081A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1081US2051081AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1082US2051082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US205-1082US2051082A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1083US2051083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US205-1083US2051083A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US205-1084US2051084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US205-1084US2051084A 2112 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US205-1084US2051084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US205-1084US2051084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1084US2051084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1085US2051085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US205-1085US2051085A 2131 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1085US2051085A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1085US2051085A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1085US2051085AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1086US2051086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US205-1086US2051086A 2183 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1086US2051086A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1086US2051086A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1086US2051086AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1087US2051087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25mRNA-1273-P201DSmRNA-1273-P201-US205-1087US2051087A 2167 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1087US2051087A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1087US2051087A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1087US2051087AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1088US2051088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25PmRNA-1273-P201DSmRNA-1273-P201-US205-1088US2051088A 2088 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US205-1088US2051088A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US205-1088US2051088A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1088US2051088AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1089US2051089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25pmRNA-1273-P201DSmRNA-1273-P201-US205-1089US2051089A 2136 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1089US2051089A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1089US2051089A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1089US2051089AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1090US2051090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US205-1090US2051090A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US205-1091US2051091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US205-1091US2051091A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US205-1092US2051092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26mRNA-1273-P201DSmRNA-1273-P201-US205-1092US2051092A 2196 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US205-1092US2051092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06BmRNA-1273-P201DSmRNA-1273-P201-US205-1092US2051092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1092US2051092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1093US2051093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26mRNA-1273-P201DSmRNA-1273-P201-US205-1093US2051093A 2163 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1093US2051093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1093US2051093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1093US2051093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1094US2051094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29mRNA-1273-P201DSmRNA-1273-P201-US205-1094US2051094A 2194 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US205-1094US2051094A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1094US2051094A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1094US2051094AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1095US2051095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-290mRNA-1273-P201DSmRNA-1273-P201-US205-1095US2051095A 2134 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1095US2051095A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1095US2051095A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1095US2051095AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1096US2051096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29pmRNA-1273-P201DSmRNA-1273-P201-US205-1096US2051096A 2166 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1096US2051096A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1096US2051096A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1096US2051096AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US205-1097US2051097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29pmRNA-1273-P201DSmRNA-1273-P201-US205-1097US2051097A 2165 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1097US2051097A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1097US2051097A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1097US2051097AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1098US2051098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29pmRNA-1273-P201DSmRNA-1273-P201-US205-1098US2051098A 2178 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1098US2051098A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-05BmRNA-1273-P201DSmRNA-1273-P201-US205-1098US2051098A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1098US2051098AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1099US2051099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29pmRNA-1273-P201DSmRNA-1273-P201-US205-1099US2051099A 2170 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1099US2051099A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1099US2051099A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1099US2051099AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1100US2051100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-290mRNA-1273-P201DSmRNA-1273-P201-US205-1100US2051100A 2132 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1100US2051100A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04B"mRNA-1273-P201DSmRNA-1273-P201-US205-1100US2051100A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1100US2051100AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1101US2051101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US205-1101US2051101A 2162 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1101US2051101A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B$mRNA-1273-P201DSmRNA-1273-P201-US205-1101US2051101A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1101US2051101AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1102US2051102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US205-1102US2051102A 2187 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1102US2051102A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1102US2051102A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1102US2051102AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1103US2051103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30 mRNA-1273-P201DSmRNA-1273-P201-US205-1103US2051103A 2146 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1103US2051103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US205-1103US2051103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1103US2051103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1104US2051104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30pmRNA-1273-P201DSmRNA-1273-P201-US205-1104US2051104A 2197 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US205-1104US2051104A0 DS-001, DS-002, DS-003AE #1, #2, AND #3 ADVERSE EVENT DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B$mRNA-1273-P201DSmRNA-1273-P201-US205-1104US2051104A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-09-02B:mRNA-1273-P201DSmRNA-1273-P201-US205-1105US2051105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30 mRNA-1273-P201DSmRNA-1273-P201-US205-1105US2051105A 2142 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1105US2051105A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US205-1105US2051105A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1105US2051105AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1106US2051106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US205-1106US2051106A 2168 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1106US2051106A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1106US2051106A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1106US2051106AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US205-1107US2051107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30 mRNA-1273-P201DSmRNA-1273-P201-US205-1107US2051107A 2140 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US205-1107US2051107A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US205-1107US2051107A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1107US2051107AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US205-1108US2051108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US205-1108US2051108A 2179 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1108US2051108A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B$mRNA-1273-P201DSmRNA-1273-P201-US205-1108US2051108A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1108US2051108AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-16BmRNA-1273-P201DSmRNA-1273-P201-US205-1109US2051109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US205-1109US2051109A 2185 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1109US2051109A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1109US2051109A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1109US2051109AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-18BmRNA-1273-P201DSmRNA-1273-P201-US205-1110US2051110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US205-1110US2051110A ENROLLMENT CLOSED OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US205-1111US2051111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US205-1111US2051111A 2188 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1111US2051111A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US205-1111US2051111A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1111US2051111AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US205-1112US2051112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US205-1112US2051112A 2169 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US205-1112US2051112A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03BmRNA-1273-P201DSmRNA-1273-P201-US205-1112US2051112A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US205-1112US2051112AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US206-1001US2061001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US206-1001US2061001A 1204 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US206-1001US2061001A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B%mRNA-1273-P201DSmRNA-1273-P201-US206-1001US2061001A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1001US2061001AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1002US2061002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1002US2061002A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US206-1003US2061003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US206-1003US2061003A 1189 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US206-1003US2061003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B!mRNA-1273-P201DSmRNA-1273-P201-US206-1003US2061003A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US206-1003US2061003AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US206-1004US2061004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1004US2061004A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US206-1005US2061005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1005US2061005A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US206-1006US2061006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US206-1006US2061006A 1126 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1006US2061006A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US206-1006US2061006A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US206-1006US2061006AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US206-1007US2061007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1007US2061007A WITHDREW CONSENT WITHDRAWAL BY SUBJECT DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1008US2061008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US206-1008US2061008A 1145 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1008US2061008A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US206-1008US2061008A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US206-1008US2061008AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US206-1009US2061009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US206-1009US2061009A 1164 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1009US2061009A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US206-1009US2061009A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1009US2061009AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1010US2061010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US206-1010US2061010A 1123 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1010US2061010A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B$mRNA-1273-P201DSmRNA-1273-P201-US206-1010US2061010A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1010US2061010AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1011US2061011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US206-1011US2061011A 1146 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1011US2061011A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US206-1011US2061011A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1011US2061011AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1012US2061012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1012US2061012A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US206-1013US2061013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US206-1013US2061013A 1208 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1013US2061013A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US206-1013US2061013A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1013US2061013AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1014US2061014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US206-1014US2061014A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US206-1015US2061015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US206-1015US2061015A 1151 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1015US2061015A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US206-1015US2061015A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1015US2061015AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1016US2061016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1016US2061016A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1017US2061017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1017US2061017A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1018US2061018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29pmRNA-1273-P201DSmRNA-1273-P201-US206-1018US2061018A 1239 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1018US2061018A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US206-1018US2061018A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1018US2061018AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1019US2061019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US206-1019US2061019A 1165 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1019US2061019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US206-1019US2061019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1019US2061019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1020US2061020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US206-1020US2061020A 1291 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US206-1020US2061020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US206-1020US2061020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1020US2061020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1021US2061021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29`mRNA-1273-P201DSmRNA-1273-P201-US206-1021US2061021A 1196 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US206-1021US2061021A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US206-1021US2061021A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1021US2061021AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1022US2061022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US206-1022US2061022A 1134 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1022US2061022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US206-1022US2061022A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1022US2061022AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1023US2061023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29pmRNA-1273-P201DSmRNA-1273-P201-US206-1023US2061023A 1215 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1023US2061023A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US206-1023US2061023A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1023US2061023AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1024US2061024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US206-1024US2061024A 1158 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1024US2061024A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US206-1024US2061024A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1024US2061024AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1025US2061025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29PmRNA-1273-P201DSmRNA-1273-P201-US206-1025US2061025A 1157 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US206-1025US2061025A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US206-1025US2061025A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1025US2061025AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1026US2061026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US206-1026US2061026A 1214 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1026US2061026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US206-1026US2061026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US206-1026US2061026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-10BmRNA-1273-P201DSmRNA-1273-P201-US206-1027US2061027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US206-1027US2061027A 1234 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1027US2061027A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US206-1027US2061027A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1027US2061027AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1028US2061028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US206-1028US2061028A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US206-1029US2061029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1029US2061029A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US206-1030US2061030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1030US2061030A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US206-1031US2061031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1031US2061031A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1032US2061032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US206-1032US2061032A 1211 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US206-1032US2061032A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US206-1032US2061032A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US206-1032US2061032AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-09BmRNA-1273-P201DSmRNA-1273-P201-US206-1033US2061033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US206-1033US2061033A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US206-1034US2061034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US206-1034US2061034A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1035US2061035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US206-1035US2061035A 1999 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US206-1035US2061035A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-20BmRNA-1273-P201DSmRNA-1273-P201-US206-1035US2061035A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1035US2061035AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1036US2061036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US206-1036US2061036A 1994 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US206-1036US2061036A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US206-1036US2061036A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1036US2061036AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1037US2061037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09mRNA-1273-P201DSmRNA-1273-P201-US206-1037US2061037A 1971 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US206-1037US2061037A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US206-1037US2061037A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1037US2061037AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US206-1038US2061038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-09.mRNA-1273-P201DSmRNA-1273-P201-US206-1038US2061038A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US206-1039US2061039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1039US2061039A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US206-1040US2061040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1040US2061040A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US206-1041US2061041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1041US2061041A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US206-1042US2061042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1042US2061042A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US206-1043US2061043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US206-1043US2061043A 2068 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US206-1043US2061043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US206-1043US2061043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1043US2061043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1044US2061044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US206-1044US2061044A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US206-1045US2061045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-10mRNA-1273-P201DSmRNA-1273-P201-US206-1045US2061045A 2073 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US206-1045US2061045A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US206-1045US2061045A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1045US2061045AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1046US2061046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US206-1046US2061046A 2067 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US206-1046US2061046A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27BmRNA-1273-P201DSmRNA-1273-P201-US206-1046US2061046A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1046US2061046AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1047US2061047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US206-1047US2061047A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US206-1048US2061048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US206-1048US2061048A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US206-1049US2061049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US206-1049US2061049A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US206-1050US2061050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US206-1050US2061050A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US206-1051US2061051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US206-1051US2061051A 2081 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US206-1051US2061051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30BmRNA-1273-P201DSmRNA-1273-P201-US206-1051US2061051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1051US2061051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1052US2061052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US206-1052US2061052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US206-1053US2061053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US206-1053US2061053A 2107 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US206-1053US2061053A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US206-1053US2061053A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1053US2061053AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1054US2061054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US206-1054US2061054A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US206-1055US2061055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US206-1055US2061055A 2075 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US206-1055US2061055A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US206-1055US2061055A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US206-1055US2061055AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US206-1056US2061056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US206-1056US2061056A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US206-1057US2061057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US206-1057US2061057A 2118 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US206-1057US2061057A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US206-1057US2061057A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1057US2061057AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1058US2061058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US206-1058US2061058A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US206-1059US2061059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US206-1059US2061059A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US206-1060US2061060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US206-1060US2061060A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US206-1061US2061061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US206-1061US2061061A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US206-1062US2061062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US206-1062US2061062A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-26.mRNA-1273-P201DSmRNA-1273-P201-US206-1063US2061063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US206-1063US2061063A 2100 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US206-1063US2061063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US206-1063US2061063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US206-1063US2061063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-11BmRNA-1273-P201DSmRNA-1273-P201-US206-1064US2061064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US206-1064US2061064A 2099 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US206-1064US2061064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US206-1064US2061064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1064US2061064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US206-1065US2061065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US206-1065US2061065A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1066US2061066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US206-1066US2061066A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US206-1067US2061067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US206-1067US2061067A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1068US2061068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24`mRNA-1273-P201DSmRNA-1273-P201-US206-1068US2061068A 2077 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US206-1068US2061068A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31B mRNA-1273-P201DSmRNA-1273-P201-US206-1068US2061068A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1068US2061068AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US206-1069US2061069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US206-1069US2061069A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US206-1070US2061070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US206-1070US2061070A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-06.mRNA-1273-P201DSmRNA-1273-P201-US206-1071US2061071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US206-1071US2061071A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US206-1072US2061072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US206-1072US2061072A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-08.mRNA-1273-P201DSmRNA-1273-P201-US207-1001US2071001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-22pmRNA-1273-P201DSmRNA-1273-P201-US207-1001US2071001A 1012 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1001US2071001A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30B!mRNA-1273-P201DSmRNA-1273-P201-US207-1001US2071001A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1001US2071001AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US207-1002US2071002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-22mRNA-1273-P201DSmRNA-1273-P201-US207-1002US2071002A 1026 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US207-1002US2071002A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US207-1002US2071002A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1002US2071002AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1003US2071003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-22mRNA-1273-P201DSmRNA-1273-P201-US207-1003US2071003A 1023 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US207-1003US2071003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US207-1003US2071003A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1003US2071003AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1004US2071004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1004US2071004A 1171 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1004US2071004A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B#mRNA-1273-P201DSmRNA-1273-P201-US207-1004US2071004A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1004US2071004AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1005US2071005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1005US2071005A 1946 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1005US2071005A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US207-1005US2071005A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1005US2071005AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1006US2071006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1006US2071006A 1938 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1006US2071006A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US207-1006US2071006A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1006US2071006AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US207-1007US2071007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1007US2071007A 1939 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1007US2071007A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US207-1007US2071007A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1007US2071007AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US207-1008US2071008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1008US2071008A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1009US2071009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1009US2071009A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1010US2071010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1010US2071010A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1011US2071011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1011US2071011A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US207-1012US2071012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1012US2071012A 1149 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1012US2071012A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US207-1012US2071012A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1012US2071012AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1013US2071013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1013US2071013A 1944 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1013US2071013A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B&mRNA-1273-P201DSmRNA-1273-P201-US207-1013US2071013A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1013US2071013AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US207-1014US2071014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1014US2071014A 1132 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1014US2071014A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US207-1014US2071014A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1014US2071014AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US207-1015US2071015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1015US2071015A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US207-1016US2071016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1016US2071016A 1144 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1016US2071016A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B$mRNA-1273-P201DSmRNA-1273-P201-US207-1016US2071016A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1016US2071016AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1017US2071017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25mRNA-1273-P201DSmRNA-1273-P201-US207-1017US2071017A 1104 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1017US2071017A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US207-1017US2071017A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-04C@mRNA-1273-P201DSmRNA-1273-P201-US207-1018US2071018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1018US2071018A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1019US2071019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1019US2071019A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1020US2071020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1020US2071020A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1021US2071021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1021US2071021A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-25.mRNA-1273-P201DSmRNA-1273-P201-US207-1022US2071022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1022US2071022A 1136 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1022US2071022A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1022US2071022A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1022US2071022AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1023US2071023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1023US2071023A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1024US2071024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1024US2071024A 1950 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1024US2071024A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US207-1024US2071024A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1024US2071024AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1025US2071025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1025US2071025A 1948 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1025US2071025A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B$mRNA-1273-P201DSmRNA-1273-P201-US207-1025US2071025A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1025US2071025AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US207-1026US2071026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1026US2071026A 1280 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1026US2071026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US207-1026US2071026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1026US2071026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CpmRNA-1273-P201DSmRNA-1273-P201-US207-1027US2071027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1027US2071027A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1028US2071028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1028US2071028A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US207-1029US2071029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1029US2071029A 1241 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1029US2071029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B$mRNA-1273-P201DSmRNA-1273-P201-US207-1029US2071029A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2020-09-28BtmRNA-1273-P201DSmRNA-1273-P201-US207-1030US2071030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1030US2071030A 1159 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1030US2071030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US207-1030US2071030A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1030US2071030AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22CmRNA-1273-P201DSmRNA-1273-P201-US207-1032US2071032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US207-1032US2071032A 1292 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1032US2071032A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B!mRNA-1273-P201DSmRNA-1273-P201-US207-1032US2071032A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US207-1033US2071033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US207-1033US2071033A 1258 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1033US2071033A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US207-1033US2071033A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1033US2071033AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CpmRNA-1273-P201DSmRNA-1273-P201-US207-1034US2071034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US207-1034US2071034A SUBJECT WAS SCREENED AS A SENTINEL SUBJECT AND VISIT WINDOW CLOSED BEFORE DAY 1 VISIT. SUBJECT IS A SF AND WILL BE RESCREENED WHEN COHORT 2 OPENS AGAIN. OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US207-1035US2071035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US207-1035US2071035A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1036US2071036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US207-1036US2071036A 1276 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1036US2071036A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US207-1036US2071036A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US207-1036US2071036AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-09C0mRNA-1273-P201DSmRNA-1273-P201-US207-1037US2071037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27pmRNA-1273-P201DSmRNA-1273-P201-US207-1037US2071037A 1947 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1037US2071037A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US207-1037US2071037A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1037US2071037AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US207-1038US2071038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US207-1038US2071038A 1187 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1038US2071038A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B(mRNA-1273-P201DSmRNA-1273-P201-US207-1038US2071038A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1038US2071038AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03CmRNA-1273-P201DSmRNA-1273-P201-US207-1039US2071039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27mRNA-1273-P201DSmRNA-1273-P201-US207-1039US2071039A 1240 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1039US2071039A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B'mRNA-1273-P201DSmRNA-1273-P201-US207-1039US2071039A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1039US2071039AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US207-1040US2071040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US207-1040US2071040A 1265 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1040US2071040A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US207-1040US2071040A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1040US2071040AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US207-1041US2071041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US207-1041US2071041A 1935 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1041US2071041A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1041US2071041A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1041US2071041AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1042US2071042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US207-1042US2071042A 1192 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1042US2071042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B$mRNA-1273-P201DSmRNA-1273-P201-US207-1042US2071042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1042US2071042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1043US2071043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US207-1043US2071043A 1949 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US207-1043US2071043A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B"mRNA-1273-P201DSmRNA-1273-P201-US207-1043US2071043A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1043US2071043AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CmRNA-1273-P201DSmRNA-1273-P201-US207-1044US2071044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28mRNA-1273-P201DSmRNA-1273-P201-US207-1044US2071044A 1274 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1044US2071044A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US207-1044US2071044A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1044US2071044AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1045US2071045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US207-1045US2071045A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US207-1046US2071046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28pmRNA-1273-P201DSmRNA-1273-P201-US207-1046US2071046A 1180 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1046US2071046A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US207-1046US2071046A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1046US2071046AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-05C0mRNA-1273-P201DSmRNA-1273-P201-US207-1048US2071048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US207-1048US2071048A EXCLUSION OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US207-1049US2071049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29`mRNA-1273-P201DSmRNA-1273-P201-US207-1049US2071049A 1174 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1049US2071049A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B#mRNA-1273-P201DSmRNA-1273-P201-US207-1049US2071049A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1049US2071049AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1050US2071050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29pmRNA-1273-P201DSmRNA-1273-P201-US207-1050US2071050A 1225 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1050US2071050A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US207-1050US2071050A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1050US2071050AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1051US2071051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29pmRNA-1273-P201DSmRNA-1273-P201-US207-1051US2071051A 1235 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1051US2071051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US207-1051US2071051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1051US2071051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1053US2071053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US207-1053US2071053A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US207-1054US2071054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US207-1054US2071054A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US207-1055US2071055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1055US2071055A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1056US2071056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1056US2071056A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US207-1058US2071058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1058US2071058A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US207-1059US2071059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01pmRNA-1273-P201DSmRNA-1273-P201-US207-1059US2071059A 1285 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1059US2071059A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US207-1059US2071059A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1059US2071059AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-05CmRNA-1273-P201DSmRNA-1273-P201-US207-1060US2071060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1060US2071060A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-10.mRNA-1273-P201DSmRNA-1273-P201-US207-1061US2071061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1061US2071061A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1062US2071062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US207-1062US2071062A 1198 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1062US2071062A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US207-1062US2071062A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1062US2071062AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1063US2071063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US207-1063US2071063A 1200 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US207-1063US2071063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B$mRNA-1273-P201DSmRNA-1273-P201-US207-1063US2071063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1063US2071063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1064US2071064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01@mRNA-1273-P201DSmRNA-1273-P201-US207-1064US2071064A 1238 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1064US2071064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B#mRNA-1273-P201DSmRNA-1273-P201-US207-1064US2071064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1064US2071064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-19CmRNA-1273-P201DSmRNA-1273-P201-US207-1065US2071065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US207-1065US2071065A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US207-1066US2071066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01mRNA-1273-P201DSmRNA-1273-P201-US207-1066US2071066A 1296 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-09AmRNA-1273-P201DSmRNA-1273-P201-US207-1066US2071066A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US207-1066US2071066A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1066US2071066AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-02CmRNA-1273-P201DSmRNA-1273-P201-US207-1067US2071067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01@mRNA-1273-P201DSmRNA-1273-P201-US207-1067US2071067A 1218 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1067US2071067A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US207-1067US2071067A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1067US2071067AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-10CpmRNA-1273-P201DSmRNA-1273-P201-US207-1068US2071068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01pmRNA-1273-P201DSmRNA-1273-P201-US207-1068US2071068A 1287 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1068US2071068A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US207-1068US2071068A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US207-1068US2071068AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US207-1069US2071069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US207-1069US2071069A 1254 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1069US2071069A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US207-1069US2071069A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1069US2071069AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25CpmRNA-1273-P201DSmRNA-1273-P201-US207-1070US2071070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US207-1070US2071070A 1260 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1070US2071070A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US207-1070US2071070A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1070US2071070AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1071US2071071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US207-1071US2071071A 1220 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1071US2071071A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B!mRNA-1273-P201DSmRNA-1273-P201-US207-1071US2071071A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1071US2071071AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1072US2071072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US207-1072US2071072A 1224 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US207-1072US2071072A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B mRNA-1273-P201DSmRNA-1273-P201-US207-1072US2071072A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1072US2071072AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1073US2071073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US207-1073US2071073A 1263 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1073US2071073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US207-1073US2071073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1073US2071073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1074US2071074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US207-1074US2071074A 1273 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1074US2071074A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US207-1074US2071074A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1074US2071074AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1075US2071075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US207-1075US2071075A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-08.mRNA-1273-P201DSmRNA-1273-P201-US207-1076US2071076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US207-1076US2071076A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US207-1077US2071077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03PmRNA-1273-P201DSmRNA-1273-P201-US207-1077US2071077A 1267 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1077US2071077A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-10B!mRNA-1273-P201DSmRNA-1273-P201-US207-1077US2071077A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-12C`mRNA-1273-P201DSmRNA-1273-P201-US207-1078US2071078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US207-1078US2071078A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US207-1079US2071079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US207-1079US2071079A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US207-1080US2071080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US207-1080US2071080A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US207-1081US2071081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US207-1081US2071081A 1288 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US207-1081US2071081A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07BmRNA-1273-P201DSmRNA-1273-P201-US207-1081US2071081A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1081US2071081AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US207-1082US2071082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US207-1082US2071082A 2030 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1082US2071082A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US207-1082US2071082A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1082US2071082AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071057A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071083A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071083A@1976 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071083AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-21BmRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071083A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1083US2071083Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22BmRNA-1273-P201DSmRNA-1273-P201-US207-1084US2071084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-05mRNA-1273-P201DSmRNA-1273-P201-US207-1084US2071084A 1975 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1084US2071084A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US207-1084US2071084A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US207-1084US2071084AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US207-1085US2071085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US207-1085US2071085A 2020 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1085US2071085A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28B!mRNA-1273-P201DSmRNA-1273-P201-US207-1085US2071085A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1085US2071085AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1086US2071086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US207-1086US2071086A 2001 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1086US2071086A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US207-1086US2071086A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1086US2071086AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1087US2071087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US207-1087US2071087A 1996 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1087US2071087A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-30B#mRNA-1273-P201DSmRNA-1273-P201-US207-1087US2071087A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1087US2071087AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29mRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071052A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071088A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071088A@2017 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071088AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071088A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1088US2071088Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26mRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071031A SCREENING VISIT AND DAY 1 WERE OUTSIDE VISIT WINDOW. SUBJECT IS A SF AND WILL BE RESCREENED. OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071089A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071089A@1967 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071089AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071089A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1089US2071089Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-25BmRNA-1273-P201DSmRNA-1273-P201-US207-1090US2071090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US207-1090US2071090A 2062 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1090US2071090A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1090US2071090A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1090US2071090AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-22BmRNA-1273-P201DSmRNA-1273-P201-US207-1091US2071091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19pmRNA-1273-P201DSmRNA-1273-P201-US207-1091US2071091A 1982 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1091US2071091A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-27B mRNA-1273-P201DSmRNA-1273-P201-US207-1091US2071091A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1091US2071091AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US207-1092US2071092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19pmRNA-1273-P201DSmRNA-1273-P201-US207-1092US2071092A 1983 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US207-1092US2071092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-21BmRNA-1273-P201DSmRNA-1273-P201-US207-1092US2071092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1092US2071092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1093US2071093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22pmRNA-1273-P201DSmRNA-1273-P201-US207-1093US2071093A 2046 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1093US2071093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1093US2071093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1093US2071093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US207-1094US2071094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US207-1094US2071094A 2164 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US207-1094US2071094A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1094US2071094A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1094US2071094AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US207-1095US2071095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23`mRNA-1273-P201DSmRNA-1273-P201-US207-1095US2071095A 2047 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1095US2071095A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US207-1095US2071095A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1095US2071095AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28#mRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071047A SUBJECT WAS SCREENED AS A SENTIEL SUBJECT. SENTINEL GROUP CLOSED PRIOR TO DAY 1 VISIT. SUBJECT WINDOW WAS UP BEFORE COHORT 2 OPENED. SUBJECT NOTED AS A SF AND WILL BE RE-SCREENED. OTHER DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071096A0 INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071096A@2148 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071096AP COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-05B#mRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071096A` INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1096US2071096Ap TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US207-1097US2071097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US207-1097US2071097A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US207-1098US2071098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24pmRNA-1273-P201DSmRNA-1273-P201-US207-1098US2071098A 2108 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US207-1098US2071098A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-05B$mRNA-1273-P201DSmRNA-1273-P201-US207-1098US2071098A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1098US2071098AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US207-1099US2071099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US207-1099US2071099A 2198 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-07AmRNA-1273-P201DSmRNA-1273-P201-US207-1099US2071099A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1099US2071099A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1099US2071099AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23BmRNA-1273-P201DSmRNA-1273-P201-US207-1100US2071100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25mRNA-1273-P201DSmRNA-1273-P201-US207-1100US2071100A 2192 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US207-1100US2071100A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-04BmRNA-1273-P201DSmRNA-1273-P201-US207-1100US2071100A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1100US2071100AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-01BmRNA-1273-P201DSmRNA-1273-P201-US207-1101US2071101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25@mRNA-1273-P201DSmRNA-1273-P201-US207-1101US2071101A 2070 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1101US2071101A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B$mRNA-1273-P201DSmRNA-1273-P201-US207-1101US2071101A@ LOST TO FOLLOW-UP LOST TO FOLLOW-UP DISPOSITION EVENT END OF STUDY BLINDED TREATMENT 2020-09-14BNmRNA-1273-P201DSmRNA-1273-P201-US207-1102US2071102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25@mRNA-1273-P201DSmRNA-1273-P201-US207-1102US2071102A 2058 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US207-1102US2071102A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-28BmRNA-1273-P201DSmRNA-1273-P201-US207-1102US2071102A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1102US2071102AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US207-1103US2071103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26`mRNA-1273-P201DSmRNA-1273-P201-US207-1103US2071103A 2147 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US207-1103US2071103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06B$mRNA-1273-P201DSmRNA-1273-P201-US207-1103US2071103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1103US2071103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19BmRNA-1273-P201DSmRNA-1273-P201-US207-1104US2071104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-26mRNA-1273-P201DSmRNA-1273-P201-US207-1104US2071104A 2172 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US207-1104US2071104A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B$mRNA-1273-P201DSmRNA-1273-P201-US207-1104US2071104A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1104US2071104AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US207-1105US2071105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-30`mRNA-1273-P201DSmRNA-1273-P201-US207-1105US2071105A 2173 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US207-1105US2071105A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B$mRNA-1273-P201DSmRNA-1273-P201-US207-1105US2071105A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-01-29BmRNA-1273-P201DSmRNA-1273-P201-US207-1105US2071105AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-01BmRNA-1273-P201DSmRNA-1273-P201-US207-1106US2071106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-07-01PmRNA-1273-P201DSmRNA-1273-P201-US207-1106US2071106A 2193 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US207-1106US2071106A0 ADVERSE EVENT (COVID-19 INFECTION) AE COVID DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-11A`mRNA-1273-P201DSmRNA-1273-P201-US207-1106US2071106A@ SUBJECT RECEIVED COVID VACCINE THROUGH OUTSIDE VENDOR WHILE PARTICIPATING IN THE TRIAL PROTOCOL DEVIATION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-03-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1001US2081001A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US208-1001US2081001A 1902 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1001US2081001A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1001US2081001A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1001US2081001AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1002US2081002A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US208-1002US2081002A 1901 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1002US2081002A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-25BmRNA-1273-P201DSmRNA-1273-P201-US208-1002US2081002A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1002US2081002AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1003US2081003A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US208-1003US2081003A 1908 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1003US2081003A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US208-1003US2081003A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15CpmRNA-1273-P201DSmRNA-1273-P201-US208-1003US2081003AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15CpmRNA-1273-P201DSmRNA-1273-P201-US208-1004US2081004A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-260mRNA-1273-P201DSmRNA-1273-P201-US208-1004US2081004A 1907 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-05-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1004US2081004A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29B mRNA-1273-P201DSmRNA-1273-P201-US208-1004US2081004A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1004US2081004AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1005US2081005A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26`mRNA-1273-P201DSmRNA-1273-P201-US208-1005US2081005A 1915 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1005US2081005A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US208-1005US2081005A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US208-1005US2081005AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C@mRNA-1273-P201DSmRNA-1273-P201-US208-1006US2081006A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US208-1006US2081006A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-26.mRNA-1273-P201DSmRNA-1273-P201-US208-1007US2081007A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US208-1007US2081007A 1913 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1007US2081007A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US208-1007US2081007A@ REQUEST TO UNBLIND POST EUA OTHER DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-06BmRNA-1273-P201DSmRNA-1273-P201-US208-1008US2081008A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1008US2081008A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1009US2081009A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US208-1009US2081009A 1914 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1009US2081009A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-02B mRNA-1273-P201DSmRNA-1273-P201-US208-1009US2081009A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1009US2081009AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1010US2081010A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1010US2081010A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1011US2081011A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1011US2081011A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US208-1012US2081012A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1012US2081012A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1013US2081013A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1013US2081013A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-27.mRNA-1273-P201DSmRNA-1273-P201-US208-1014US2081014A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US208-1014US2081014A 1923 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1014US2081014A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US208-1014US2081014A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1014US2081014AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1015US2081015A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US208-1015US2081015A 1924 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1015US2081015A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US208-1015US2081015A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1015US2081015AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1016US2081016A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-27PmRNA-1273-P201DSmRNA-1273-P201-US208-1016US2081016A 1918 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1016US2081016A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1016US2081016A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1016US2081016AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1017US2081017A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US208-1017US2081017A 1934 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1017US2081017A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US208-1017US2081017A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US208-1017US2081017AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US208-1018US2081018A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1018US2081018A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1019US2081019A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US208-1019US2081019A 1936 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1019US2081019A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-30BmRNA-1273-P201DSmRNA-1273-P201-US208-1019US2081019A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1019US2081019AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1020US2081020A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28PmRNA-1273-P201DSmRNA-1273-P201-US208-1020US2081020A 1937 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1020US2081020A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1020US2081020A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1020US2081020AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1021US2081021A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1021US2081021A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1022US2081022A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1022US2081022A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1023US2081023A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US208-1023US2081023A 1139 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1023US2081023A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US208-1023US2081023A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C@mRNA-1273-P201DSmRNA-1273-P201-US208-1023US2081023AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C@mRNA-1273-P201DSmRNA-1273-P201-US208-1024US2081024A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1024US2081024A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-28.mRNA-1273-P201DSmRNA-1273-P201-US208-1025US2081025A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-28`mRNA-1273-P201DSmRNA-1273-P201-US208-1025US2081025A 1127 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1025US2081025A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B#mRNA-1273-P201DSmRNA-1273-P201-US208-1025US2081025A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1025US2081025AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1026US2081026A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29`mRNA-1273-P201DSmRNA-1273-P201-US208-1026US2081026A 1166 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US208-1026US2081026A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US208-1026US2081026A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1026US2081026AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1027US2081027A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1027US2081027A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1028US2081028A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US208-1028US2081028A 1091 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1028US2081028A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US208-1028US2081028A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US208-1028US2081028AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US208-1029US2081029A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US208-1029US2081029A 1942 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1029US2081029A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US208-1029US2081029A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US208-1029US2081029AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17CPmRNA-1273-P201DSmRNA-1273-P201-US208-1030US2081030A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US208-1030US2081030A 1940 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1030US2081030A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-06B#mRNA-1273-P201DSmRNA-1273-P201-US208-1030US2081030A@ PATIENT UNBLINDED, DISENROLLED DUE TO PATIENT DESIRE TO RECEIVE OUTSIDE VACCINE OF ANOTHER MANUFACTURER. OTHER DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-25BmRNA-1273-P201DSmRNA-1273-P201-US208-1031US2081031A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1031US2081031A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1032US2081032A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1032US2081032A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1033US2081033A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US208-1033US2081033A 1049 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1033US2081033A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B$mRNA-1273-P201DSmRNA-1273-P201-US208-1033US2081033A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US208-1033US2081033AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15C0mRNA-1273-P201DSmRNA-1273-P201-US208-1034US2081034A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1034US2081034A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1035US2081035A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29@mRNA-1273-P201DSmRNA-1273-P201-US208-1035US2081035A 1941 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1035US2081035A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-01BmRNA-1273-P201DSmRNA-1273-P201-US208-1035US2081035A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1035US2081035AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1036US2081036A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29`mRNA-1273-P201DSmRNA-1273-P201-US208-1036US2081036A 1169 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US208-1036US2081036A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B$mRNA-1273-P201DSmRNA-1273-P201-US208-1036US2081036A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US208-1036US2081036AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CmRNA-1273-P201DSmRNA-1273-P201-US208-1037US2081037A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-05-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1037US2081037A COHORT FULL MET ELIGIBILITY CRITERIA BUT NOT NEEDEDDISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-12.mRNA-1273-P201DSmRNA-1273-P201-US208-1038US2081038A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01pmRNA-1273-P201DSmRNA-1273-P201-US208-1038US2081038A 1242 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1038US2081038A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US208-1038US2081038A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US208-1038US2081038AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US208-1039US2081039A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01pmRNA-1273-P201DSmRNA-1273-P201-US208-1039US2081039A 1264 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1039US2081039A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1039US2081039A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1039US2081039AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1040US2081040A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1040US2081040A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1041US2081041A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US208-1041US2081041A 1182 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US208-1041US2081041A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US208-1041US2081041A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US208-1041US2081041AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US208-1042US2081042A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01mRNA-1273-P201DSmRNA-1273-P201-US208-1042US2081042A 1297 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-10AmRNA-1273-P201DSmRNA-1273-P201-US208-1042US2081042A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1042US2081042A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1042US2081042AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1043US2081043A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1043US2081043A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1044US2081044A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1044US2081044A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1045US2081045A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-010mRNA-1273-P201DSmRNA-1273-P201-US208-1045US2081045A 1170 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-04AmRNA-1273-P201DSmRNA-1273-P201-US208-1045US2081045A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-07B"mRNA-1273-P201DSmRNA-1273-P201-US208-1045US2081045A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1045US2081045AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1046US2081046A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02`mRNA-1273-P201DSmRNA-1273-P201-US208-1046US2081046A 1275 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1046US2081046A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US208-1046US2081046A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US208-1046US2081046AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-23CPmRNA-1273-P201DSmRNA-1273-P201-US208-1047US2081047A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1047US2081047A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1048US2081048A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1048US2081048A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1049US2081049A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02pmRNA-1273-P201DSmRNA-1273-P201-US208-1049US2081049A 1293 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-09AmRNA-1273-P201DSmRNA-1273-P201-US208-1049US2081049A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1049US2081049A@ REQUEST TO UNBLIND POST EUA OTHER DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-01-06BmRNA-1273-P201DSmRNA-1273-P201-US208-1050US2081050A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1050US2081050A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-05.mRNA-1273-P201DSmRNA-1273-P201-US208-1051US2081051A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US208-1051US2081051A 1207 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US208-1051US2081051A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US208-1051US2081051A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C mRNA-1273-P201DSmRNA-1273-P201-US208-1051US2081051AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17C mRNA-1273-P201DSmRNA-1273-P201-US208-1052US2081052A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-020mRNA-1273-P201DSmRNA-1273-P201-US208-1052US2081052A 1213 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US208-1052US2081052A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B#mRNA-1273-P201DSmRNA-1273-P201-US208-1052US2081052A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1052US2081052AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-12CmRNA-1273-P201DSmRNA-1273-P201-US208-1053US2081053A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1053US2081053A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1054US2081054A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US208-1054US2081054A 1223 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US208-1054US2081054A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08B"mRNA-1273-P201DSmRNA-1273-P201-US208-1054US2081054A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1054US2081054AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1055US2081055A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1055US2081055A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1056US2081056A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1056US2081056A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-03.mRNA-1273-P201DSmRNA-1273-P201-US208-1057US2081057A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-03 mRNA-1273-P201DSmRNA-1273-P201-US208-1057US2081057A 1222 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-05AmRNA-1273-P201DSmRNA-1273-P201-US208-1057US2081057A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B#mRNA-1273-P201DSmRNA-1273-P201-US208-1057US2081057A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US208-1057US2081057AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24CmRNA-1273-P201DSmRNA-1273-P201-US208-1058US2081058A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04@mRNA-1273-P201DSmRNA-1273-P201-US208-1058US2081058A 1256 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1058US2081058A0 PER CRA, POSITIVE COVID SWAB WAS REPORTED IN ERROR BY PPD LABS. PATIENT IS NO LONGER WITHIN WINDOW TO RECEIVE 2ND DOSE. OTHER DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-06-17AmRNA-1273-P201DSmRNA-1273-P201-US208-1058US2081058A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US208-1058US2081058AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-19CmRNA-1273-P201DSmRNA-1273-P201-US208-1059US2081059A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04@mRNA-1273-P201DSmRNA-1273-P201-US208-1059US2081059A 1270 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1059US2081059A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-13B$mRNA-1273-P201DSmRNA-1273-P201-US208-1059US2081059A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1059US2081059AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1060US2081060A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US208-1060US2081060A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US208-1061US2081061A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US208-1061US2081061A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-04.mRNA-1273-P201DSmRNA-1273-P201-US208-1062US2081062A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US208-1062US2081062A 1248 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1062US2081062A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US208-1062US2081062A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1062US2081062AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1063US2081063A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US208-1063US2081063A 1243 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1063US2081063A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1063US2081063A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1063US2081063AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24C`mRNA-1273-P201DSmRNA-1273-P201-US208-1064US2081064A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-050mRNA-1273-P201DSmRNA-1273-P201-US208-1064US2081064A 1255 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1064US2081064A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-09B mRNA-1273-P201DSmRNA-1273-P201-US208-1064US2081064A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1064US2081064AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26CmRNA-1273-P201DSmRNA-1273-P201-US208-1065US2081065A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US208-1065US2081065A 1951 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1065US2081065A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1065US2081065A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1065US2081065AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1066US2081066A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US208-1066US2081066A 1989 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1066US2081066A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1066US2081066A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1066US2081066AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1067US2081067A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US208-1067US2081067A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US208-1068US2081068A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11.mRNA-1273-P201DSmRNA-1273-P201-US208-1068US2081068A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1069US2081069A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-11mRNA-1273-P201DSmRNA-1273-P201-US208-1069US2081069A 2014 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1069US2081069A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1069US2081069A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1069US2081069AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1070US2081070A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US208-1070US2081070A 1986 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1070US2081070A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1070US2081070A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1070US2081070AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1071US2081071A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-12mRNA-1273-P201DSmRNA-1273-P201-US208-1071US2081071A 2084 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US208-1071US2081071A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1071US2081071A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1071US2081071AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1072US2081072A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US208-1072US2081072A 1964 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1072US2081072A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1072US2081072A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1072US2081072AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1073US2081073A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US208-1073US2081073A 1966 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1073US2081073A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1073US2081073A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1073US2081073AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1074US2081074A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US208-1074US2081074A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-15.mRNA-1273-P201DSmRNA-1273-P201-US208-1075US2081075A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-15mRNA-1273-P201DSmRNA-1273-P201-US208-1075US2081075A 2089 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US208-1075US2081075A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1075US2081075A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1075US2081075AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1076US2081076A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US208-1076US2081076A 2104 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1076US2081076A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-05B$mRNA-1273-P201DSmRNA-1273-P201-US208-1076US2081076A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1076US2081076AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-24BmRNA-1273-P201DSmRNA-1273-P201-US208-1077US2081077A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16mRNA-1273-P201DSmRNA-1273-P201-US208-1077US2081077A 2092 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US208-1077US2081077A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B#mRNA-1273-P201DSmRNA-1273-P201-US208-1077US2081077A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1077US2081077AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1078US2081078A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-16.mRNA-1273-P201DSmRNA-1273-P201-US208-1078US2081078A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1079US2081079A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US208-1079US2081079A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-17.mRNA-1273-P201DSmRNA-1273-P201-US208-1080US2081080A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US208-1080US2081080A 2109 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1080US2081080A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1080US2081080A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1080US2081080AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1081US2081081A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-17mRNA-1273-P201DSmRNA-1273-P201-US208-1081US2081081A 2043 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1081US2081081A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1081US2081081A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1081US2081081AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1082US2081082A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1082US2081082A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1083US2081083A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1083US2081083A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1084US2081084A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1084US2081084A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1085US2081085A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US208-1085US2081085A 2159 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1085US2081085A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B(mRNA-1273-P201DSmRNA-1273-P201-US208-1085US2081085A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1085US2081085AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-03-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1086US2081086A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1086US2081086A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1087US2081087A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US208-1087US2081087A 2074 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US208-1087US2081087A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1087US2081087A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1087US2081087AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1088US2081088A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18mRNA-1273-P201DSmRNA-1273-P201-US208-1088US2081088A 2126 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1088US2081088A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US208-1088US2081088A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1088US2081088AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1089US2081089A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1089US2081089A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-18.mRNA-1273-P201DSmRNA-1273-P201-US208-1090US2081090A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US208-1090US2081090A 2102 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1090US2081090A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B"mRNA-1273-P201DSmRNA-1273-P201-US208-1090US2081090A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US208-1090US2081090AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-26BmRNA-1273-P201DSmRNA-1273-P201-US208-1091US2081091A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US208-1091US2081091A 2155 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1091US2081091A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B mRNA-1273-P201DSmRNA-1273-P201-US208-1091US2081091A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1091US2081091AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1092US2081092A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US208-1092US2081092A 2128 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1092US2081092A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1092US2081092A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1092US2081092AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1093US2081093A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19mRNA-1273-P201DSmRNA-1273-P201-US208-1093US2081093A 2130 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1093US2081093A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US208-1093US2081093A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1093US2081093AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1094US2081094A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US208-1094US2081094A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US208-1095US2081095A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US208-1095US2081095A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1096US2081096A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US208-1096US2081096A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-19.mRNA-1273-P201DSmRNA-1273-P201-US208-1097US2081097A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US208-1097US2081097A 2103 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1097US2081097A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1097US2081097A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1097US2081097AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1098US2081098A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US208-1098US2081098A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-01.mRNA-1273-P201DSmRNA-1273-P201-US208-1099US2081099A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22@mRNA-1273-P201DSmRNA-1273-P201-US208-1099US2081099A 1952 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-26AmRNA-1273-P201DSmRNA-1273-P201-US208-1099US2081099A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29B"mRNA-1273-P201DSmRNA-1273-P201-US208-1099US2081099A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1099US2081099AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1100US2081100A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22mRNA-1273-P201DSmRNA-1273-P201-US208-1100US2081100A 2138 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1100US2081100A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US208-1100US2081100A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1100US2081100AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1101US2081101A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US208-1101US2081101A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US208-1102US2081102A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-22.mRNA-1273-P201DSmRNA-1273-P201-US208-1102US2081102A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1103US2081103A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US208-1103US2081103A 2124 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1103US2081103A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06B$mRNA-1273-P201DSmRNA-1273-P201-US208-1103US2081103A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1103US2081103AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1104US2081104A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US208-1104US2081104A 2125 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1104US2081104A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-06B$mRNA-1273-P201DSmRNA-1273-P201-US208-1104US2081104A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1104US2081104AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1105US2081105A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1105US2081105A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1106US2081106A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1106US2081106A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1107US2081107A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1107US2081107A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1108US2081108A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US208-1108US2081108A 2157 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1108US2081108A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1108US2081108A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1108US2081108AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-08BmRNA-1273-P201DSmRNA-1273-P201-US208-1109US2081109A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23.mRNA-1273-P201DSmRNA-1273-P201-US208-1109US2081109A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1110US2081110A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-23mRNA-1273-P201DSmRNA-1273-P201-US208-1110US2081110A 2156 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1110US2081110A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1110US2081110A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1110US2081110AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-12BmRNA-1273-P201DSmRNA-1273-P201-US208-1111US2081111A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US208-1111US2081111A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US208-1112US2081112A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US208-1112US2081112A 2158 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-03AmRNA-1273-P201DSmRNA-1273-P201-US208-1112US2081112A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B(mRNA-1273-P201DSmRNA-1273-P201-US208-1112US2081112A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1112US2081112AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1113US2081113A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US208-1113US2081113A 2200 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-08AmRNA-1273-P201DSmRNA-1273-P201-US208-1113US2081113A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B"mRNA-1273-P201DSmRNA-1273-P201-US208-1113US2081113A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1113US2081113AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1114US2081114A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US208-1114US2081114A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-07-02.mRNA-1273-P201DSmRNA-1273-P201-US208-1115US2081115A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US208-1115US2081115A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-24.mRNA-1273-P201DSmRNA-1273-P201-US208-1116US2081116A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24PmRNA-1273-P201DSmRNA-1273-P201-US208-1116US2081116A 2063 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-29AmRNA-1273-P201DSmRNA-1273-P201-US208-1116US2081116A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1116US2081116A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1116US2081116AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1117US2081117A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US208-1117US2081117A 2171 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US208-1117US2081117A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B%mRNA-1273-P201DSmRNA-1273-P201-US208-1117US2081117A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1117US2081117AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-05BmRNA-1273-P201DSmRNA-1273-P201-US208-1118US2081118A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24pmRNA-1273-P201DSmRNA-1273-P201-US208-1118US2081118A 2113 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1118US2081118A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-31BmRNA-1273-P201DSmRNA-1273-P201-US208-1118US2081118A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1118US2081118AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1119US2081119A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US208-1119US2081119A 2160 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US208-1119US2081119A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B%mRNA-1273-P201DSmRNA-1273-P201-US208-1119US2081119A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1119US2081119AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1120US2081120A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24pmRNA-1273-P201DSmRNA-1273-P201-US208-1120US2081120A 2119 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-01AmRNA-1273-P201DSmRNA-1273-P201-US208-1120US2081120A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-07-29BmRNA-1273-P201DSmRNA-1273-P201-US208-1120US2081120A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1120US2081120AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1121US2081121A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-24mRNA-1273-P201DSmRNA-1273-P201-US208-1121US2081121A 2161 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-06AmRNA-1273-P201DSmRNA-1273-P201-US208-1121US2081121A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-10B$mRNA-1273-P201DSmRNA-1273-P201-US208-1121US2081121A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1121US2081121AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-03BmRNA-1273-P201DSmRNA-1273-P201-US208-1122US2081122A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1122US2081122A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-30.mRNA-1273-P201DSmRNA-1273-P201-US208-1123US2081123A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25PmRNA-1273-P201DSmRNA-1273-P201-US208-1123US2081123A 2085 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-06-30AmRNA-1273-P201DSmRNA-1273-P201-US208-1123US2081123A0 DS-001 AE LOGLINE #1 ADVERSE EVENT DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-11B+mRNA-1273-P201DSmRNA-1273-P201-US208-1123US2081123A@ DR. WILLIAMS DOES NOT FEEL THAT SUBJECT SHOULD RECEIVE ANOTHER DOSE OF STUDY VACCINE DUE TO SAES. DR. WILLIAMS DETERMINED IT WAS IN THE SUBJECT'S BEST INTEREST TO NO LONGER PARTICIPATE.PHYSICIAN DECISION DISPOSITION EVENT END OF STUDY PART A FOLLOW-UP 2021-02-17BmRNA-1273-P201DSmRNA-1273-P201-US208-1124US2081124A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1124US2081124A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.mRNA-1273-P201DSmRNA-1273-P201-US208-1125US2081125A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25pmRNA-1273-P201DSmRNA-1273-P201-US208-1125US2081125A 2143 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1125US2081125A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US208-1125US2081125A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1125US2081125AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-02BmRNA-1273-P201DSmRNA-1273-P201-US208-1126US2081126A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1126US2081126A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1127US2081127A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1127US2081127A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1128US2081128A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1128US2081128A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1129US2081129A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25pmRNA-1273-P201DSmRNA-1273-P201-US208-1129US2081129A 2144 RANDOMIZED RANDOMIZED PROTOCOL MILESTONE 2020-07-02AmRNA-1273-P201DSmRNA-1273-P201-US208-1129US2081129A0 COMPLETED COMPLETED DISPOSITION EVENT STUDY TREATMENTBLINDED TREATMENT 2020-08-03B!mRNA-1273-P201DSmRNA-1273-P201-US208-1129US2081129A@ INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1129US2081129AP TREATMENT UNBLINDED TREATMENT UNBLINDED PROTOCOL MILESTONEOPEN LABEL 2021-02-15BmRNA-1273-P201DSmRNA-1273-P201-US208-1130US2081130A INFORMED CONSENT OBTAINED INFORMED CONSENT OBTAINED PROTOCOL MILESTONE 2020-06-25.mRNA-1273-P201DSmRNA-1273-P201-US208-1130US2081130A INCLUSION/EXCLUSION SCREEN FAILURE DISPOSITION EVENT SCREEN FAILURE SCREENING 2020-06-29.